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Abstract 
Three-dimensional (3D) segmentation of the prostate in medical images is useful 
for prostate cancer diagnosis and therapy guidance. However, manual segmentation of 
the prostate is laborious and time-consuming with inter-observer variability at the 
prostatic apex, mid-gland, and base. The focus of this thesis was on: (1) accuracy, 
reproducibility and procedure time measurement for prostate segmentation on T2-
weighted endorectal (ER) magnetic resonance (MR) imaging (MRI), and (2) assessment 
of the potential of a computer-assisted segmentation technique to be translated to clinical 
practice for prostate cancer management. 
We collected 42 ER MR images from patients with biopsy-confirmed prostate 
cancer. Prostate border delineation was manually performed by one observer on all the 
images and by two other observers on a subset of 10 images. 
We developed a novel semi-automatic and automatic prostate segmentation 
algorithms that identify candidate prostate boundary points using learned local prostate 
border appearance characteristics, which were regularized according to learned prostate 
shape information to produce the final segmentation. The main novelties of the 
algorithms are that the segmentations was based on local appearance similarity of the 
prostate border across patients, rather than on the appearance of the entire image. This 
makes the appearance-based segmentation more robust to inter-patient variation of 
prostate gland internal appearance that could be caused by variable spatial distribution of 
cancer in the patients. We evaluated our method against the manual reference 
segmentations using mean absolute distance (MAD), Dice similarity coefficient (DSC), 
recall rate, precision rate, and volume difference as a complementary boundary-, region- 
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and volume-based error metric set to measure the different types of observed 
segmentation errors. We applied this evaluation for expert manual segmentation as well 
as semi-automatic and automatic segmentation approaches before and after manual 
editing by expert physicians. Physicians were instructed to edit the segmentations to their 
satisfaction for use in clinical procedures, as would be done with any prostate 
segmentation technique integrated into the clinical workflow. We recorded the time 
needed for user interaction to initialize the semi-automatic algorithm, algorithm 
execution, and manual editing where applicable. 
On 42 images, comparing to a single-observer manual segmentation reference, the 
measured errors for semi-automatic and automatic algorithm on whole prostate gland 
were, respectively, MAD of 2.0 mm and 3.2 mm; DSC of 82% and 71%; recall of 77% 
and 69%; precision of 88% and 76%; and ΔV of -4.6 cm3 and -3.6 cm3. These results 
compared favourably with observed difference between manual segmentation and a 
simultaneous truth and performance level estimation (STAPLE) reference for a subset of 
10 images (whole gland differences as high as MAD = 3.1 mm, DSC = 78%, recall = 
66%, precision = 77%, and ΔV = 15.5 cm3). For each 3D image, the semi-automatic 
algorithm required about 30 seconds, on average, to be initialized. Using an unoptimized 
Matlab research platform on a single CPU core, the average execution times for semi-
automatic and automatic algorithm were 85 seconds and 54 seconds, respectively, to 
segment a prostate MRI in 3D. We also measured average editing times of 330 and 390 
seconds for the semi-automatic and automatic segmentation results, respectively, whereas 
an expert spent 210 seconds on average editing manual segmentations performed by 
another expert. Inter-operator variability resulting from using our computer-assisted 
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algorithms to generate starting segmentations for manual editing was not substantially 
higher than that resulting from using expert manual segmentations as starting 
segmentations, suggesting a role for our (semi-)automated segmentation algorithm in this 
context. 
The presented algorithms used learned local appearance characteristics and 
prostate shape separately to segment the prostate and regularize the segmentation, 
respectively. The semi-automatic algorithm needed minimal user interaction of 
approximately 30 seconds to be initialized; this was replaced by about 3 seconds of 
computational time using the automatic segmentation. Both algorithms are highly 
parallelizable. 
The main conclusions of this thesis were that: (1) computer-assisted segmentation 
approaches reduced the inter-observer segmentation variability compared to manual 
segmentation, (2) the accuracy of the computer-assisted approaches was near to or within 
the range of observed variability in manual prostate segmentation performed by experts, 
(3) manual editing of semi-automated and automated segmentation approaches improved 
the accuracy and inter-operator variability, (4) the recorded procedure time for prostate 
segmentation was reduced using computer-assisted segmentation approaches followed by 
manual editing  compared to fully manual segmentation, and (5) starting the manual 
segmentation from an initial computer-assisted segmentation label could yield lower 
variability in the final segmentations and the choice of automatic vs. semi-automatic 
segmentation comes down to operator preference. 
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Chapter 1. 
  
Introduction 
Three-dimensional (3D) segmentation of the prostate in medical images is useful 
for diagnosis and treatment planning of prostate cancer (PCa) [1, 2]. Magnetic resonance 
imaging (MRI) is increasingly being utilitized for PCa diagnosis and staging [3]. More 
specifically, T2-weighted (T2w) MRI is superior to other MRI sequences in anatomy 
visualization and is most commonly used for contouring the prostate boundary [3]. 
Endorectal receiver (ER) coil MRI provides improved image quality by increasing the 
contrast and signal-to-noise ratio [4-6]. However, the ER coil causes substantial 
deformation of the prostate tissue [7, 8] and also renders fine details and edges more 
salient in the magnetic resonance (MR) images, presenting an additional challenge to 
segmentation algorithms developed for use on MR images acquired without an ER coil. 
Manual contouring of the prostate on MRI is a time-consuming task with substantial 
inter-observer variability [9]. This is an important issue in clinical trials involving 
multiple investigators performing radiation therapy planning, in which inter-operator 
variation in contouring could materially impact the trial results. The impact of inter-
operator contouring variability on clinical outcomes is unknown and has not yet been 
extensively studied [1]. 
Manual contouring of the prostate is a labourious and time-consuming task [10, 
11]. Employing a computer-assisted algorithm for prostate segmentation could facilitate 
the contouring task by making it faster with minimal required user interaction. It also 
could help in the establishment of clinical methods that require the prostate to be 
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segmented more than once during the course of the treatment. For example, recontouring 
the prostate over the course of radiation therapy (RT) could help radiotherapists to adjust 
the plan based on the evolving condition of the patient [12]. 
Several algorithms have been presented in the literature for 3D segmentation of 
the prostate on T2W MRI acquired with an ER coil [13-16]. Predominantly, in the 
published studies the accuracy of the segmentation results was evaluated by comparison 
to a single-observer reference standard manual segmentation of each image in the data 
set. However, due to high inter-observer variation in manual contouring of the prostate by 
experts, there is no gold standard for prostate contouring on MRI [1] and this challenges 
the comparison of error metric values obtained from different segmentation algorithms on 
different data sets. Furthermore, in most studies, the choice of segmentation error metrics 
is somewhat arbitrary and not determined based on clinical demands [1]. The use of a set 
of complementary error metrics to capture most types of medically relevant segmentation 
errors is beneficial to assessing an algorithm’s suitability for clinical translation. 
Comparing two commonly-used metrics, surface-based error metrics such as the mean 
absolute distance (MAD) between segmentation boundaries are usually more sensitive to 
local misalignments of the shape surfaces. Region-based metrics such as the Dice 
similarity coefficient (DSC), are measured based on the overlap area or volume and they 
are less sensitive to error types like sharp local surface misalignments. The 
appropriateness of a particular method depends on the intended use of the segementation. 
For example, a local surface misalignment in radiation therapy could be neglected using a 
region-based error metric but this error might cause an overdose of healthy tissues or an 
underdose of the tumour volume. 
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The focus of this thesis is to comprehensively evaluate the prostate segmentation 
accuracy and inter-operator variability and to compare novel semi-automatic and fully 
automatic computer-assisted segmentation algorithms with manual segmentation in terms 
of accuracy, reproducibility and required operator interaction time. The remainder of this 
chapter describes PCa prevalence and its clinical diagnosis and treatment methods; the 
role of medical imaging, specifically MRI, in diagnosis and treatment planning of the 
PCa; and the role of prostate contouring in MRI-guided or MRI-targeted procedures. 
1.1 Anatomy of the prostate gland 
The prostate is a part of the reproductive and urinary system of the male human 
body. A normal and healthy prostate is usually a walnut-sized gland that is located just 
below the bladder, anterior to the rectum and posterior to the pubic symphysis. It has an 
inverted pyramid shape with the base abutting the bladder and the apex abutting the 
urogenital diaphragm (Figure 1.1). It surrounds the bladder neck and the urethra. 
Additional structures such as seminal vesicles, neurovascular bundles (NVBs) and 
muscles also surround the prostate gland. Figure 1.1 shows the prostate location in the 
male reproductive system. 
The prostate gland is divided into three different zones with different embryologic 
origins: the peripheral zone, transition zone, and central zone. In a healthy prostate, the 
peripheral zone forms about 70% of the prostate gland volume. It surrounds the urethra at 
the prostate apex and extends posterolaterally to the prostate base. The central zone 
contains the ejaculatory ducts and accounts for about 25% of the prostate tissue. The 
transition zone comprises only 5% to 10% of the gland volume and is located between 
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the peripheral and the central zones. Figure 1.2 shows the anatomy of the prostate gland 
and its zones. 
 
 
Figure 1.1: Prostate location in the reproductive system of the male human body. 
Adapted from [17]. 
 
Figure 1.2: Prostate gland zonal anatomy. CZ: central zone, TZ: transition zone, and PZ: 
peripheral zone 
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1.2 Prostate cancer and its prevalence 
PCa is the most commonly diagnosed cancer in men in North America, excluding 
skin cancer [18, 19]. The American Cancer Society predicts that in 2015 over 220,000 
new cases of PCa will be diagnosed; this represents approximately one quarter of all 
cancers among men. The American Cancer Society also predicts over 27,000 deaths from 
PCa in the United States in 2015 [18]. In Canada, one out of eight men will be diagnosed 
with PCa within his lifetime. Approximately 24,000 new cases of PCa are predicted to be 
diagnosed in Canada in 2015. PCa is also the second cause of death by cancer among 
Canadian men [19]. About 98% of PCa cases occur in men aged 50 years and older [20]. 
Prostate tumour cells develop in widely different patterns, at different growth 
rates, and with different aggressiveness and metastatic ability. There also exist benign 
prostate tumours that are not cancerous. Benign tumours can cause problems, such as 
pain and urination difficulties, but usually they are not life threatening and they do not 
spread to other organs of the body. Due to the wide variation in prostate tumour types, 
accurate and reliable diagnosis of PCa is vital for planning effective treatment that is 
appropriate to the aggressiveness level of the disease. Tumour size, location and extent, 
and the type of carcinoma are considered by clinicians during treatment selection. 
1.3 Prostate cancer screening and diagnosis 
In general, screening means testing for a disease in healthy and asymptomatic 
populations to identify and treat the disease at earlier stages, whereas diagnosis refers to 
detecting disease among individuals having symptoms and signs. Since PCa is usually 
asymptomatic in the early stages, there are some screening tests such as digital rectal 
examination (DRE), prostate-specific antigen (PSA) blood testing and transrectal 
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ultrasound (TRUS) imaging [21] to help in identifying the PCa in its early stages. It has 
been shown that about 75% of PCa would not be diagnosed early without PSA screening 
in the population [22] and there is no doubt that early diagnosis of aggressive PCa is 
helpful to preventing cancer spread to other organs. An early and accurate diagnosis helps 
to treat the patient more efficiently and effectively. However, screening in PCa is still a 
controversial subject [23-26]. On one hand, there is evidence that PCa screening could 
reduce the rate of advanced and metastatic PCa [25, 26]. On the other hand, there is a 
higher probability of missing a fast-growing tumour in the interval between PCa 
screening tests [24], implying that screening is a less effective approach for diagnosis of 
fast-growing PCa tumours compared to slow-growing tumours that are usually less life-
threatening. Moreover, early diagnosis of PCa through screening tests could be also 
harmful due to potential overdiagnosis and overtreatment of the disease [23]. 
Overtreatment of PCa is especially concerning in patients for whom treatment is 
associated with minimal benefit compared to active surveillance (e.g. patients older than 
65 years [27]). 
The success of screening processes depends on two principal conditions: (1) there 
are available tests to detect the disease at the early stages, and (2) there are effective 
treatments for the disease at the early stages [24]. Therefore, to improve the benefits of 
screening it is necessary to improve the accuracy, sensitivity and specificity of the cancer 
detection methods as well as the efficiency of the treatment procedures. 
In the following subsections, we briefly introduce the standard tests that are 
typically used for PCa screening and diagnosis. 
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1.3.1 Digital rectal examination 
DRE is a PCa screening test. During the test, the physician uses a gloved 
lubricated finger to palpate the prostate gland through rectum to examine the prostate for 
any irregularities in shape, size and texture (Figure 1.3). The detection rate of DRE by 
itself is low [28]. Sensitivities of 40% to 55% has been reported in the literature for DRE 
[28-30]. However, there are cancers that are detected by DRE alone or could be 
diagnosed through DRE earlier than with PSA blood testing and ultrasound imaging [31]. 
Therefore, considering also the simplicity and availability of the test, DRE is routinely 
used for screening. 
 
Figure 1.3: Digital rectal examination (DRE) Adapted from [17].  
 
1.3.2 Prostate specific antigen test 
PSA is a protein that is produced by the prostate gland and released into the 
bloodstream. Most of the time, when an abnormality such as PCa occurs in the prostate, 
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more PSA is released into the blood stream. During a PSA test, a small amount of blood 
is taken and the level of PSA in the blood is measured. A high level of PSA in the blood 
or a rapid elavation of the PSA level over time are considered as signs of suspicion for 
PCa. 
There is not any level of PSA in the blood defined as normal. However, 
traditionally, PSA levels of 4 ng/mL are considered as a cutoff point to distinguished 
normal from abnormal. PSA levels above 10 ng/mL are usually considered as high PSA 
level that is suspicious for advanced or metastatic PCa. According to American Cancer 
Society guidlines for early detection of PCa, if the PSA level is lower than 2.5 ng/mL, 
screening could be conducted every two years, and for PSA levels of 2.5 ng/mL and 
above the screening interval should be one year. It also suggests biopsy for men at 
average risk for PCa whose PSA level is 4.0 ng/mL or greater. For individuals at high 
risk for cancer when the PSA level is within the range of 2.5 ng/mL to 4.0 ng/mL 
individualized diagnosis planning is suggested [32]. 
1.3.3 Prostate biopsy 
Patients with abnormal DRE or high or elevated PSA levels are referred for 
prostate biopsy [32]. Currently, prostate needle biopsy is the clinical standard for 
diagnosis of PCa. This is an outpatient procedure which is done under local anesthesia. 
During the biopsy process a thin needle is inserted through either the rectal wall 
(transrectal biopsy) or the perineum and usually 6 to 24 (typically about 12) small 
samples of the prostate are taken from different parts of the gland [33]. Transrectal 
prostate biopsy is most common. This process is usually done under two-dimensional 
(2D) TRUS imaging guidance. Figure 1.4 shows a schematic depicting transrectal 
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prostate biopsy. The biopsy samples are sent to a pathology laboratory, where a 
pathologist looks at the specimens under a microscope and reports on the presence and 
grade of PCa. The pathologist categorizes cancerous foci using a standard grading system 
called the Gleason grading system [34]. The number of biopsy samples that are cancerous 
and the percentage of cancer in each biopsy core are also reported. Since about 30% of 
cancers are missed during the first TRUS-guided prostate biopsy [35, 36], for individuals 
with persistently elevated PSA or positive DRE whose initial biopsy did not detect 
cancer, repeat biopsy is required [36]. 
  
Figure 1.4: Diagram depicting transrectal prostate biopsy. Adapted from [17]. 
1.3.4 Grading and staging of prostate cancer 
PCa grading: The Gleason system is one of the most commonly used systems for 
gradig PCa in pathological samples. The Gleason system was first presented in 1966 by 
Donald F. Gleason [37] and it became more popular in North America in the late 1980s 
and early 1990s. The grading system is based on tissue architecture at the cellular level 
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and refers to identification of aggressiveness of the cancer cells based on their histologic 
pattern of arrangement [34]. In the Gleason grading system, nine fundamental tumour cell 
patterns are defined under 5 grades; grade 1 to grade 5, with lower grades being closer to 
normal tissue and higher grades being more aggressive. Within the prostate, the first and 
second most predominant Gleason grades are added together and reported as Gleason 
score or Gleason sum. The higher the Gleason score, the higher chance of harbouring 
PCa tumours with potential to grow and spread quickly. 
PCa staging: PCa is also characterized based on how much cancer has spread 
within or beyond the prostate border; this is referred to as PCa staging. There is a strong 
relationship between PCa stage and the probability of curative treatment. The tumour-
node-metastasis (TNM) staging system presented by the American Joint Committee on 
Cancer is one of the most commonly used cancer staging methods worldwide [38]. It 
categorizes PCa into four main stages; taking the size of the tumour, the extent to which 
lymph nodes are involved, and the presence of metastases into account. Gleason grading 
of the tumour is also considered in the staging process. In stage I, cancer foci are usually 
microscopic and cannot be detected during DRE, the PSA level is lower than 10 ng/mL, 
and the Gleason score is less than or equal to 6. In this stage, cancer is usually detected 
through biopsy and few of the obtained samples are cancerous. In stage II, cancer is 
confined to the prostate gland and may be detected by DRE. In this stage, PSA could rise 
up to 20 ng/mL or higher. In stage III, the tumour has extended beyond the prostate 
capsule, but no regional lymph node metastasis or distant metastasis is detected. In stage 
IV, cancer has invaded adjacent tissues and organs. In this stage, metastasis in regional 
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lymph node(s) and/or other organs might be found [38]. Table 1.1 presents a brief and 
general overview of the TNM staging system for PCa. 
Table 1.1: Prostate cancer staging using the TNM system. This table is adapted and 
summarized from [38]. N0 means no regional lymph node metastasis and N1 means 
regional lymph node metastasis. M0 means no distant metastasis and M1 means 
metastasis in other organs beyond the prostate gland. 
Stage Tumour 
Regional 
lymph node 
metastasis 
Distant 
metastasis 
PSA level* 
(ng/mL) 
Gleason 
score* 
I 
Microscopic nonpalpable 
tumour confined to prostate 
capsule 
N0 M0 < 10 ≤ 6 
IIA 
Tumour confined to 
prostate capsule and 
involving 50% or less of 
one lobe 
N0 M0 <20 ≤ 7 
IIB 
Tumour confined to 
prostate capsule and 
involving either more than 
50% of one lobe, or both 
lobes 
N0 M0 any any 
III 
Tumour expansion beyond 
the prostate  
N0 M0 any any 
IV 
Tumour invasion of 
adjacent structures beyond 
the prostate 
N0/N1 M0/M1 any any 
* Where available 
1.3.5 Other diagnosis methods 
Medical imaging: Ultrasound imaging is one of the imaging methods currently 
performed as a clinical follow up method to the DRE and PSA blood tests to measure the 
prostate gland size, as well as the PCa tumour size, location and extent. Ultrasound 
imaging is also used for guidance of clinical procedures such as prostate biopsy or 
brachytherapy. 2D TRUS imaging is the most common method used for PCa diagnosis or 
guidance of some of the clinical procedures. Between 25% and 40% of PCa tumours have 
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been reported as isoechoic [39-41], meaning that they are not detected through ultrasound 
imaging. 
Bone scan: Bones are usually the first target of metastasis in prostate cancer. 
Therefore a bone scan or bone scintigraphy is usually used as a follow up test for high-
grade and/or high-stage PCa. The bone scan is a nuclear imaging method in which a low-
level radioactive material (called a radiotracer) is injected into a vein and this material is 
absorbed by bones. A gamma camera, which is a radiation-sensitive device, scans the 
body and detects the radiation emitted by the radiotracer. The more active the bone, the 
more radiotracer will be absorbed and detected by the camera. Some tumours, infections, 
bone abnormalities  and bone damage show up as sites of increased radiotracer uptake 
and are demonstrated as hot spot areas on imaging. The hot spots might suggest cancer 
metastasis to the bone or they might be detected because of some other bone 
abnormalities. 
1.3.6 Risk groups 
PCa patients are categorized into six different risk groups based on the initial 
clinical assessment: very low-, low-, intermediate-, high-, very high-risk, or metastatic 
cancer. These risk groups are used to choose the appropriate treatment option for the 
patients. If a patient’s risk group changes over a period of time, this is strongly suggestive 
of cancer progression and indicates radical treatments such as surgery or radiotherapy 
[42]. Table 1.2 shows the six risk factors and their characteristics. In the next subsection 
(1.3.7) we describe the clinical treatment plan that is suggested for each risk group. 
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1.3.7 Early diagnosis clinical workflow 
The National Comprehensive Cancer Network (NCCN) has published a guideline 
that suggests a clinical workflow for PCa diagnosis and treatment planning [42]. In this 
guideline for early detection of the PCa, initial risk assessment based on DRE and PSA is 
suggested. Biopsy is usually offered based on DRE and PSA results. For individuals of 
45 to 75 years of age with normal DRE and PSA level lower than 1 ng/mL, repeating 
DRE and PSA at 2-4 years intervals is suggested. If the PSA level is equal to or higher 
than 1ng/mL, or the individual’s age is above 75 years with a PSA level lower than 3 
ng/mL, DRE and PSA testing are offered every 1–2 years. For individuals with PSA level 
above 3.0 ng/mL, the NCCN guidline suggests workup for benign disease; i.e., either 
TRUS-guided biopsy or PSA and DRE testing every 6–12 months [43]. 
Table 1.2: Prostate cancer risk groups. This table is adapted from [44]. 
Risk group PCa extent Staging 
 Gleason 
score 
 PSA level 
(ng/mL) 
Very low 
Clinically 
localized 
Stage I 
≤ 5% tissue involvement 
< 3 positive biopsy cores  
(< 50% cancer in each)  
and ≤ 6 and < 10 
Low 
Clinically 
localized 
Stage I or II 
≤ 50% of one lobe is involved 
and 2 to 6 and < 10 
Intermediate 
Clinically 
localized 
Stage II 
> 50% of one lobe or both lobes are 
involved 
or 7  or 10-20 
High 
Clinically 
localized 
Stage III 
Extracapsular extension 
or 8-10 or > 20 
Very high 
Locally 
advanced 
Stage III or IV 
Seminal vesicle(s) invasion 
 any  any 
Metastatic Metastatic 
Regional lymph and/or distant 
metastasis 
 any  any 
 
For treatment planning, NCCN guidelines suggest a specific strategy for each risk 
group. The recommended strategies are usually based on the estimated life expectancy of 
the patient and PCa growth and progression over time. The suggested treatment options 
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could be selected from active surveillance (i.e. active monitoring of disease progression), 
radiotherapy (brachytherapy or external beam radiotherapy; EBRT) and surgery (radical 
prostatectomy with or without pelvic lymph node dissection). In some cases, androgen 
deprivation therapy or ADT is also recommended, usually combined with the radical 
treatments such as EBRT or radical prostatectomy [44]. 
1.4 Prostate cancer treatment 
1.4.1 Radical treatments 
Surgery: Currently, one of the clinical standard PCa treatments is to surgically 
remove the whole prostate gland and the attached seminal vesicles, also known as radical 
prostatectomy. This surgery is usually done for patients with clinically localized PCa that 
is progressive and aggressive. Some times the local lymph nodes are also removed during 
the same surgery [44]. Radical prostatectomy is sometimes followed by other treatment 
or monitoring options such as radiotherapy, chemotherapy, ADT or active surveillance to 
avoid the risk of PCa recurrence [45]. 
Since the prostate is surrounded by the sphincter urethrae muscle, as well as 
nerves and blood vessels that are critical for erections, and is attached to many organs 
such as rectum and bladder, radical prostatectomy can have severe side effects such as 
urinary incontinence and erectile dysfunction [46-48]. Prostatectomy has minimal post-
surgery bowel function-related symptoms [49]. The NCCN guidelines recommend radical 
prostatectomy for patients with 10 or more years of estimated life expectancy who do not 
have any serious health conditions that would contraindicate the surgery [44]. 
External beam radiation therapy: EBRT is another common radical treatment 
option for PCa, where ionizing radiation (e.g. X-ray) is generated and delivered to the 
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target by a computer-controlled linear accelerator (LINAC). The LINAC targets the 
prostate and directs the radiation from outside of the body at the prostate gland to kill the 
cancerous cells. Intensity modulated radiotherapy (IMRT) is one of the state-of-art 
radiathion therapy methods in radiation oncology used for PCa treatment. With IMRT, 
compared to traditional radiation therapy, oncologists can plan the radiation therapy with 
the aim of delivering a higher dose to the tumour and minimizing radiation exposure to 
the healthy surrounding tissues. For accurate radiation delivery to the target, prostate 
localization is performed by image-guided radiotherapy (IGRT) [44]. In IGRT, for each 
radiation delivery secssion the target is tracked by an intra-operative imaging system such 
as ultrasound imaging, X-ray imaging or cone-beam computed tomography (CT) to 
increase the accuracy of the targeting and compensate tissue movment. 
Prostate EBRT dose planning is usually done under CT image guidance because 
CT provides 3D anatomical localization of the pelvis and also provides the electron 
density information of the tissues that is required for radiation dose calculation. Radiation 
oncologists usually use inverse planning for radiation dose planning in IMRT. In inverse 
planning the oncologists first delineate the prostate border as well as the surfaces of all 
organs at risk in 3D. They then use advanced software to prioritize the dose delivery and 
limitations for the organs at risk and run the software to design the dose plan. The dose 
plan is used in a computer-controlled LINAC for radiation therapy delivery. 
The limitation with CT based planning is the low soft tissue contrast in CT 
images. Therefore, CT cannot provide accurate and repeatable contour delineation for the 
prostate and some of the surrounding organs at risk such as the rectum, bladder and 
NVBs [50, 51]. 
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In terms of health-related quality of life (HRQOL), in general, patients who 
undergo EBRT have less urinary incontinence but worse bowel function compared to 
prostatectomy patients [52, 53]. HRQOL improves over time post-treatment for PCa 
patients treated with EBRT [54]. EBRT also avoids surgery-associated risks and 
complications such as bleeding and transfusion-related risks, and anesthesia-associated 
side effects [44]. 
Brachytherapy: Brachytherapy, as an internal radiotherapy, is another radical 
treatment method usually used for lower-risk PCa cases [44]. In this method, radioactive 
sources are placed within the prostate tissue to kill the cancerous cells. Prostate 
brachytherapy is an outpatient procedure that is performed under either general or spinal 
anesthesia. The treatment is usually planned using ultrasound and/or MR imaging. The 
radioactive sources are usually placed in the prostate through transperineal insertion 
under the guidance of an imaging technique like TRUS [55]. 
Low dose-rate (LDR) and high dose-rate (HDR) brachytherapy are the two main 
types of brachytherapy treatment approaches for PCa. In HDR brachytherapy a catheter is 
inserted into the prostate and a high-dose radiation is delivered to the cancerous tissue. In 
LDR brachytherapy a number of small radioactive seeds are permanently implanted in 
the prostate gland to deliver low dose radiation to the tumour cells within a longer period 
of time compared to HDR brachytherapy. Brachytherapy as monotherapy is 
recommended to patients with low-risk PCa. For intermediate-risk PCa, brachytherapy is 
combined with EBRT with or without ADT. Brachytherapy rarely is a useful option for 
high-risk PCa treatment [44]. 
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Brachytherapy is usually performed within a day and the patient can return to 
normal activities in a short time [44]. Less erectile dysfunction is reported after 
brachytherapy compared to EBRT and prostatectomy [49]. The incidence of urinary 
continence is lower after brachytherapy compared to prostatectomy, and bowel 
dysfunction is comparable to EBRT [49, 52]. 
1.4.2 Lesion-directed treatments 
In a subset of prostate cancer patients with organ-confined cancer, PCa consists of 
a dominant high-grade tumour surrounded by primarily non-cancerous tissue. Therefore, 
a number of emerging therapy methods such as cryotherapy and high intensity focused 
ultrasound (HIFU) suggest preserving as much healthy parenchyma as possible and 
delivering the treatment to the tumour site [44]. In these local therapy methods (also 
known as focal therapies) the treatment is focused on the tumour cells to spare healthy 
tissues from destruction. This leads to minimally invasive treatments with fewer and less-
severe risks and side effects compared to radical treatments like prostatectomy and 
radiotherapy. 
1.5 Prostate cancer imaging 
There are many different imaging modalities that are being used for PCa 
diagnostic and therapeutic procedures. For each clinical procedure, the imaging modality 
to be utilitzed is chosen according to the features required for that type of procedure. 
Sometimes it is required or more effective to use combination of two or more imaging 
methods. Ultrasound, CT, MRI and positron emission tomography (PET) are the most 
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popular imaging modalities that are currently being used for PCa diagnosis or treatment 
in clinical procedures. 
1.5.1 Ultrasound imaging 
As is also mentioned in section 1.3.5, ultrasound imaging and more specifically 
TRUS imaging is the most common imaging modality used for PCa diagnosis and 
treatment. It is an inexpensive and safe imaging modality that is available in most clinical 
centres. In TRUS imaging, a transrectal ultrasound transducer is inserted into the rectum 
and acquires images from the prostate gland through the rectal wall. TRUS is capable of 
displaying the anatomy of the prostate and provides real time imaging with rates of up to 
30 frames per second. There are two types of TRUS probe available that provide different 
views; end-firing and side-firing probes. Both probe types are currently used in clinical 
procedures such as TRUS-guided biopsy but the preference of one over the other is still a 
matter of debate [56-59]. However, for prostate biopsy, end-firing probes are 
recommended because they provide greater freedom of biopsy plane manipulation and 
they enable better access to the peripheral zone, where PCa tumours are most likely to be 
found [57, 59]. Side-firing probes are mostly used in transperineal biopsy or 
brachytherapy. 
TRUS is one of the imaging modalities used for accurate estimation of the 
prostate gland volume [60]. It is also used for PCa detection and tumour volume 
estimation, however ultrasound imaging is not able to detect all prostate tumours; about 
25 to 40 percent of PCa tumours have been reported as isoechoic [39-41]. 
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1.5.2 Computed tomography imaging 
CT is an imaging modality based on X-ray irradiation of the body from different 
angles and processing the acquired data by a computer to generate the images. CT 
provides each 3D image in the form of a set of cross-sectional images. The CT image 
intensities are directly correlated with the electron density of the tissues. This is an 
exclusive feature of CT imaging that is required for radiation dose calculation during the 
radiotherapy planning process. However, X-rays forms the CT images, image contrast is 
lower for soft tissues compared to the image contrast for hard tissues (e.g. bones). For 
prostate imaging, although CT imaging provides a useful 3D anatomical image of the 
pelvis, prostate contouring on CT images is challenging and subject to high inter-
observer variability compared to other imaging modalities such as ultrasound and MRI 
[9, 61, 62]. 
1.5.3 Magnetic resonance imaging 
MRI is known as a noninvasive medical imaging method. MRI uses a strong 
magnetic field (usually 0.5 to 3.0 Tesla) and radio frequency (RF) pulses (with frequency 
of ~42.5 MHz/Tesla) to generate the cross-sectional images of the body. MRI yields 
high-contrast, detailed images of soft tissues. However, for air and bone imaging the 
quality of MR images is poor, and additional techniques such as using contrast agents are 
required. 
MRI is capable of producing 3D images in the form of a set of cross-sectional 2D 
images. There are three orthogonal standard imaging planes defined in radiology to 
present cross-sectional views: the axial, sagittal, and coronal imaging planes. The axial 
plane (also known as the transverse plane) divides the body into superior and inferior 
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parts (Figure 1.5 (a)). The sagittal imaging plane (also known as the lateral plane) is 
perpendicular to the axial plane and divides body into left and right parts (Figure 1.5 (b)). 
The coronal imaging plane (also known as the frontal plane) is perpendicular to the axial 
and sagittal planes and divides the body into anterior (ventral) and posterior (dorsal) parts 
(Figure 1.5 (c)). 
  
Figure 1.5: Three standard imaging planes in radiology. (a) Axial plane, (b) sagittal 
plane, and (c) coronal plane. 
1.5.3.1 Prostate MRI 
Although MRI is not used as a clinical standard test for PCa [63-65], MRI has 
demonstrated its potential and important role as an imaging modality for PCa 
management [63-68]. Over the past two decades, in many centres MR imaging has been 
Axial Sagittal Coronal
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used for PCa diagnosis, staging, treatment planning and therapy guidance [65-67, 69]. 
Most commonly, prostate MRI is performed at 1.5 or 3.0 Tesla magnetic field strength. In 
some centres, an ER coil and/or pelvic phased array coil (also known as a body coil) are 
used for prostate MRI to increase the signal-to-noise ratio (SNR) and improve the spatial 
resolution of the images [7, 70]. Although the optimal use of the ER coil for prostate MRI 
is still under study, there is some evidence of improvement in diagnosis and staging of 
PCa using ER MRI [7, 70, 71]. Figure 1.6 shows the same axial cross-section of the 
prostate on T2w MRI acquired with and without ER coil from the same patient. 
 
Figure 1.6: Axial view of T2w prostate MRI acquired (a) without, and (b) with ER coil. 
Both images are midgland slices of the same patient  
There are several different MR imaging pulse sequences available for prostate 
that form multiparametric MRI; e.g. T1-weighted MRI, T2w MRI, dynamic contrast 
enhanced (DCE) MRI, diffusion weighted imaging (DWI), and MR spectroscopy (MRS) 
[65]. 
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1.5.3.2 Multiparametric MRI 
T1- and T2-weighted MRI: T1- and T2-weighted MRI are both used for PCa 
detection [72]. T1-weighted MRI is also used for detection of hemorrhage after prostate 
biopsy [72]. The zonal anatomy of the prostate is appreciated better on T2w MRI 
compared to T1-weighted MRI, and therefore usually T2w MRI is used as a main 
imaging approach for anatomy description of the prostate and adjacent tissues [73-75]. In 
T2w MRI of the healthy prostate, the peripheral zone appears brighter than the central 
and transitional zones, which are mixed dark to semi-bright regions on the image [76]. In 
T2w MRI, a hypointense area within the peripheral zone is considered to be PCa unless a 
hyperintense area (i.e. usually associated with the post-biopsy hemorrhage) is observed at 
the same location on T1-weighted MRI [77]. However, in some cases, PCa is challenging 
to detect on T2w MRI, because PCa can occur within an isointense region or even a 
hyperintense area compared to the background [70]. Sensitivity and specificity for T2w 
MRI in PCa detection have been reported as 52% to 83%, and 46% to 83%, respectively 
[78]. 
Contouring of the prostate on MRI is used for localizing the prostate border with 
surrounding tissues to help clinicians deliver the treatment to the prostate gland, and more 
specifically, to the PCa tumour sites while preserving healthy surrounding tissues from 
harm. Due to its better anatomical definition, the contouring task is often performed on 
T2w MR images. Furthermore, T2w MRI is useful in assessing the PCa extent and its 
spread beyond the prostate border. Hence, prostate border localisation on this MRI 
sequence could be helpful to staging. 
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Dynamic contrast enhanced MRI: For acquisition of DCE MRI, an MRI contrast 
agent is injected into the body and the changes in contrast agent uptake and washout by 
the prostate tissue are measured through acquisition of a time series of T1-weighted MR 
images. DCE MRI is useful for detecting, localising, and staging of PCa [79, 80]. It has 
shown high sensitivity and specificity for early detection of PCa [79]. 
Diffusion weighted imaging: DWI is another type of MRI in which the mobility of 
water molecules at the microscopic level is measured. DWI measures the apparent 
diffusion coefficient (ADC) value that reflects the water diffusion pattern in the tissue. 
The idea behind clinical DWI is that, in general, the water motion in healthy human body 
tissues with intact cell microstructures is oriented and anisotropic. In a pathological 
change in tissue these microstructures are destroyed, therefore, the pattern of water 
diffusion in the tissue is more isotropic [81]. DWI has a short acquisition time and 
usually provides high-contrast between PCa and normal tissue and is useful in PCa 
diagnosis. However, because of low SNR, the spatial resolution of DWI is low [82]. 
MR spectroscopy: MRS is used in combination with MRI to provide more 
information about tissue characteristics [83]. Similar to MRI, MRS is also based on the 
nuclear magnetic resonance phenomenon. It provides information about the metabolic 
activity of the prostate by measuring the quantities of some metabolites (e.g. choline, 
citrates, creatine and polyamines) within the prostate gland. The metabolite quantities or 
the ratio between them indicate different abnormalities of the prostate [82]. One of the 
most important metabolite change in PCa is related to the level of citrate [84]. 
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1.5.3.3 Endorectal receiver coil 
In MRI and MRS, the smaller the receiver RF coil and the closer the coil is 
located to the target, the lower the noise level. Body and ER coils are two common RF 
receiver coils that are used in prostate MRI to enhance the quality of MR images in terms 
of spatial resolution and SNR [70]. The most common ER coil  used in prostate MRI is 
an inflatable ER coil that consists of a probe with a inflatable latex cover, also called a 
balloon. The balloon is filled by either air, perfluorocarbon, or barium after insertion into 
rectum for better positioning and coverage, and less coil motion [85]. Typically, the 
inflated ER coil has a cylindrical shape with about 8.5 cm length and about 4.5 cm 
diameter after inflation [7, 70]. 
Despite improvement in image quality via the ER coil, the ER coil complicates 
some aspects of imaging. For example, the ER coil substantially displaces and deforms 
the prostate [7]. On average, it compresses the prostate gland about 15% 
anteroposteriorly, and expands it about 8% in the left-right direction [7]. In MRI-targeted 
image-guided procedures, MRI information is often combined with another imaging 
modality (such as intra-procedural TRUS). Therefore, the deformation of the prostate 
shape challenges image alignment between MRI and the other imaging modality. In 
EBRT, CT imaging (the standard imaging modality for dose calculation) is acquired with 
no prostate gland deformation and in TRUS-guided procedures, although the endorectal 
transducer is used, the shape of the transducer and the way it is located inside the rectum 
is different and therefore the prostate shape is deformed in a different way [7]. Another 
limitation related to the use of the ER coil is the presence of some image distortion and 
artifacts such as magnetic susceptibility, coil flare, and rectum movement artifacts [86]. 
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Figure 1.7 shows some types of imaging artifacts that occur on ER MRI. Some 
distortions, e.g. magnetic susceptibility, occur because of the air-inflated ER coil and can 
be reduced by replacing air with other ER coil balloon filling materials [85]. 
Furthermore, since the ER coil is placed posterior to the prostate, it generates an 
inhomogeneity in the received signal and, accordingly, in the image intensities [87]. In 
MRI, the voxel intensities are higher close to the coil. 
 
Figure 1.7: ER coil distortion on MRI [86]: (a) gland distortion, (b) near-field coil flare 
artifact, (c) coil-related artifact because of air-inflated balloon, and (d) rectal movement 
distortion. 
(a) (b)
(c) (d)
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Although the ER coil improves image quality overall and some studies have 
shown a positive impact of using ER coil on MRI-based PCa diagnosis [6, 69, 71, 88-90], 
the use of the ER coil for prostate MRI is still debated because the coil is not comfortable 
for the patients and generates image distortions. One study suggested that the ER coil 
does not significantly improve MRI power in diagnosis of PCa [86]. Another study [91] 
has shown that in terms of staging accuracy, non-ER 3.0 Tesla MRI is equivalent to ER 
1.5 Tesla MRI. 
1.5.4 Nuclear imaging 
Some types of nuclear imaging methods such as PET are also used for prostate 
imaging. PET scanning cannot provide accurate anatomical information; however, it can 
detect tumours based on the metabolic functionality of the tissues. Sometimes a 
combination of PET and another imaging modality such as CT (called PET/CT) is used to 
generate high-resolution anatomic images fused with functional images [92]. Since the 
metabolic glucose activity of PCa is low, fluorodeoxyglucose (FDG)-PET scanning is 
less useful for PCa diagnosis particularly in the early stages, but is usually used in 
metastasis detection [92]. There are studies that show the role of other radiotracers in 
PET imaging for early detection of PCa [93]. 
1.6 The role of MRI in diagnosis and treatment of prostate cancer 
1.6.1 MRI-targeted TRUS-guided biopsy 
Due to lack of visibility of many PCa tumours on TRUS, the standard TRUS-
guided prostate biopsy is usually performed based on a systematic sampling approach 
from different regions of the prostate gland [33]. About 35% of PCa is not detected 
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during the first attempt at TRUS-guided biopsy [36]. Since MRI yields improved ability 
for detecting and localizing of PCa [63-69], there are some recently developed biopsy 
systems that utilize MR images to define biopsy targets, and map those targets to the real-
time intra-operative TRUS images to help clinicians direct the biopsy needles to the pre-
defined suspicious regions. It has been shown that this has increased the detection rate of 
biopsy and decreased the rate of repeat biopsy [94-96]. 
1.6.2 MRI-CT fusion radiotherapy planning 
The CT scan is very important for dose calculation in radiation therapy planning 
because it provides the electron density distribution of body tissues as well as useful 
anatomical information. For dose planning, it is also important to identify the boundaries 
of the prostate and surrounding sensitive tissues and organs. Since the soft tissue contrast 
on CT images is lower than on MRI, contouring the prostate on CT could result in lower 
accuracy and higher intra- and inter-observer variability [9, 50]. It is also nearly 
impossible to detect or localize prostate tumours in CT images. One way to account for 
inter-observer variability in radiotherapy planning is to use an expanded safety margin 
around the boundary, but this can cause undesirable irradiation of surrounding healthy 
tissues. Another way is to improve the accuracy and consistency of the border delineation 
using MR imaging. However, in MRI, there is not a unique correspondence between 
pixel intensity and electron density. Poor imaging of bones and image distortions are the 
other disadvantages of using MRI for dose planning. To address these challenges, one 
approach is to use MRI-to-CT image fusion that enables using MRI-based delineated 
borders on CT images for radiotherapy planning. It has been shown in the literature that 
using MRI guidance for prostate EBRT planning could increase the accuracy and 
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repeatability of the planning [62, 97, 98]. There are also studies on MRI-only 
radiotherapy planning methods in which CT imaging has been omitted [99]. To estimate 
the electron density information of the tissues, the MR image is segmented and different 
values are assigned to different regions based on the characteristics of the tissues. The 
MRI-only methods overcome the image registration and fusion errors. However, the 
accuracy of dosimetry is affected due to lack of accurate electron density information 
within the tissues. 
1.6.3 MRI-guided biopsy and focal therapy 
The increasing potential of MRI for diagnosis, localisation, and staging of PCa 
has driven the development of diagnostic and therapeutic devices that are compatible 
with the MRI magnetic field and imaging approach and can be used inside the MRI bore. 
MRI-guided biopsy [75] and MRI-guided focal therapy [100] are two examples of MRI-
guided procedures in which MRI-compatible devices are used. In these procedures, the 
traditional intra-procedure imaging modality is replaced by MRI to increase the accuracy 
of the procedures by avoiding image fusion and registration errors. This comes with the 
compromise of increased cost of the procedure and awkward patient positioning issues 
due to the confines of the MRI bore. 
1.7 Prostate contouring on MRI 
Delineation of the prostate gland on MRI plays an important role in some 
diagnostic and therapeutic procedures. It helps to define the anatomy of the organ and to 
measure its volume. Measurement of the volume is useful for diagnosis and treatment 
planning. For example, the PSA level is usually interpreted in the context of prostate 
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volume [101]. Contouring of the prostate on MRI could be also helpful either in planning 
and delivering an MRI-guided therapy, or in the fusion of MR images to other imaging 
modalities (e.g. CT or ultrasound) for running an MRI-targeted image-guided process. 
However, there are uncertainties and challenges around manual contouring of the 
prostate on MRI, described below. 
1.7.1 Challenges in manual prostate contouring in MRI 
Accuracy and reproducibility: The prostate is a soft tissue organ that is 
surrounded by other soft tissue structures such as the bladder, seminal vesicles, muscles, 
NVBs, and penile bulb. It has been shown using histology that the prostate is not a fully 
encapsulated gland, and the adjacent tissues in some parts are blended with the 
periprostatic tissues [102]. Thus, for some portions of the prostate, there does not exist a 
discrete, “true” boundary, even when viewed under the microscope. This poses 
challenges to prostate boundary delineation on medical imaging, rendering manual 
contouring a challenging task that is subject to relatively high intra- and inter-observer 
variability [9, 103]. This variability is even higher within some parts of the prostate such 
as base and apex regions [103]. This contouring variability could potentially influence the 
outcomes of clinical procedures, and also could cause a lack of performance consistency 
of a similar procedure between different clinical centres in multi-centre trials [1]. 
Therefore, any approach that helps to reduce this variability and improve the 
reproducibility of the task could be helpful from clinical point of view.  
Timing: Contouring time is another issue with manual contouring of the prostate 
on MRI. There are several reports that report manual prostate contouring times, with the 
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average contouring time for the whole prostate in 3D varying between five minutes [10] 
up to approximately 20 minutes [11]. 
1.7.2 Computer-assisted prostate segmentation on MRI  
In some clinical applications, computer-assisted contouring of the images (also 
called image segmentation) can provide more accurate and reproducible results in a 
shorter time. Segmentation is an image processing method in which the image usually is 
divided into two non-overlapped homogeneous regions with respect to some image 
characteristics such as intensity or texture [104]. One region is the region of interest 
(ROI) or object and the other is the background. 
There are different types of approaches available for image segmentation in 
medical imaging. Segmentation algorithms work based on the features that are extracted 
from the image; e.g. image intensities, textures, intensity gradients or edges [105]. Some 
methods like thresholding and pixel clustering are based on pixel classificaltion and some 
others could be based on edge, boundary or shape detection. Sometimes a combination of 
multiple image-derived features is used to segment an image. There is also a group of 
segmentation methods that segment an image based on prior knowledge about image 
structure and characteristics obtained from a training image set. 
Segmentation algorithms are usually designed or modified to optimize the result 
for specific applications. There are several presented image segmentation algorithms 
available in the literature for prostate segmentation in MRI, as described in a recent 
survey [106]. These algorithms have been developed to make the image contouring either 
faster, more accurate and/or more repeatable. 
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1.7.2.1 User interaction 
There are two types of segmentation algorithm; semi-automatic and automatic. In 
semi-automatic segmentation, some operator interaction is required. Interaction allows 
for incorporation of the operator’s domain knowledge into the process of the image 
segmentation. Usually, operator interaction improves the accuracyof the algorithm and 
makes the algorithm more robust, but it could make the algorithm laborious and time-
consuming  to use. In automatic segmentation, the computer segments the image with no 
operator interaction required. However, automatic segmentation algorithms usually 
require parameter tuning by a user for initialization [104]. 
1.7.2.2 Prostate MRI segmentation challenges 
As explained earlier, using the ER coil improves MR image quality from a 
clinical point of view, but can render computer-assisted segmentation more challenging 
due to the higher contrast within the prostate that reveals many details and edges that are 
not pertinent to the prostate boundary itself. Segmentation on ER MRI is also challenged 
by intensity inhomogeneity artifacts [85] and other artifacts as described in subsection 
1.5.3.3. Thus, prostate segmentation on ER MRI is a substantially different problem, 
compared to prostate segmentation on MRI acquired with a body coil. 
1.7.2.3 Prostate ER MRI segmentation techniques 
There are several techniques have been presented in the literature for 
segmentation of the prostate on T2w MRI acquired with an ER coil. Martin et al. [13] 
presented a semi-automatic atlas-based method using intensity information combined 
with few landmarks to register an atlas to a test image. They evaluated their algorithm 
within different ROIs, including the midgland, base and apex, using a distance-based 
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error metric, and for the whole gland using region-based metrics. They reported some 
difficulties using atlas registration for small prostates with volume less than 25 cm3 that 
resulted in higher segmentation errors. Vikal et al. [14] utilized shape modeling for a 
slice-by-slice 3D segmentation of the prostate on T2w MRI. Their semi-automatic 
method needed one centre point for initialisation and each slice segmentation was used as 
the initialisation for the segmentation of the next slice. They evaluated their method on 
three T2w ER MR images acquired at 3.0 Tesla using the MAD and DSC metrics to 
measure performance. Toth and Madabhushi [15] presented a semi-automatic 
segmentation method using a landmark-free active appearance model. They used a level 
set-based shape representation for their method. The method has been evaluated using the 
MAD and DSC error metrics selectively for different ROIs. Liao et al. [16] presented a 
hierarchical automatic segmentation using a multi-atlas-based method for coarse 
segmentation of the target image followed by a semisupervised regularization for the 
final fine segmentation. They evaluated their method on 66 T2w MR images using MAD, 
DSC, and Hausdorff distance (HD) metrics for the whole gland. Cheng et al. [107] 
presented an automatic atlas-based approach for T2w prostate MRI segmentation. Their 
algorithm is a slice-by-slice segmentation in which first an adaptive active appearance 
model is used to provide an initial coarse segmentation and then a support vector 
machine-based approach is used to refine the segmentation. Their evaluated their method 
using region based metrics on the whole gland.  
In 2012, the Medical Image Computing and Computer Assisted Intervention 
(MICCAI) conference held a prostate MR image segmentation (PROMISE12) challenge 
in which 11 teams were involved. The challenge evaluated the prostate T2w algorithms 
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presented by the teams and compared their performance in two parts; an online challenge 
and a live challenge. The data set contained both ER and non-ER MR images. DSC, 
MAD, 95% HD, and the percentage of the relative volume difference metrics were used 
to evaluate the algorithms. The metrics were applied to the whole gland, as well as the 
base and apex regions separately. PROMISE12 is a valuable study that measured and 
compared the segmentation errors of different state-of-the-art methods using the same 
data set to test and a single reference to evaluate [108]. 
Alvarez et al. [109] presented an automatic segmentation method for T2w 
prostate and tested their algorithm on 50 images from the PROMISE12 data set, 
including 24 ER MR images. In their method, for each test image a subset of similar 
training images are selected using a multi-scale analysis, and then the segmentation labels 
from the training images are registered to the test image and locally combined using a 
patch-based approach. Their results were sensitive to the number of atlases used and the 
size of the patches. They used the DSC measured on the whole gland to evaluate their 
method against a manual reference segmentation. Table 1.3 provides a high-level 
comparison of all of these approaches. 
Table 1.3 gives a brief overview on all the mentioned segmentation methods. 
Although there are several segmentation algorithms available in the literature for which 
the segmentation accuracy is asymptotically approaching the observed range of 
differences between experts in manual segmentation, there remain some important 
limitations. For example, for some of the techniques the complexity of the algorithms is 
high. This complexity resulted in longer computational time ([15, 16]) compared to the 
methods with less complexity, but did not make a meaningful difference in segmentation 
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accuracy. Furthermore, some methods are not readily amenable to speed-up through 
parallel computing implementation.  
1.7.3 Validation challenges 
1.7.3.1 Lack of gold standard 
The high inter-observer variability in manual contouring of the prostate MRI 
challenges the preparation a single gold-standard reference segmentation for each image. 
The absence of a reference to define the true extent of an object makes it difficult to 
validate the absolute accuracy of the contouring results [1]. The use of a single observer’s 
manual contours as a reference standard thus complicates the interpretation of the results. 
Where different observers’ reference standard segmentations were used in different 
studies, this poses a challenge to comparing different algorithms since differing results 
could be attributed to inter-observer variability in manual contouring rather than in true 
differences between algorithm performance. Combining a set of different contours from a 
group of experts as a consensus of opinion to make one reference standard is an approach 
to mitigate this issue and simplify validation. Simultaneous truth and performance level 
estimation (STAPLE) [110] is one of the most common approaches for combining a set 
of segmentation using a weighted voting scheme. 
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Table 1.3: A survey of prostate MRI segmentation algorithms. 
Authors Techniques 
Field 
strength 
(Tesla) 
ER 
coil 
Validation 
regions 
Validation 
metrics 
Data set 
size 
Number 
of 
references 
Martin et al. [13] Atlas-based X yes 
WG, A, MG, B MAD 
18 one 
WG 
Recall, 
Precision 
Vikal et al. [14] 
Shape modeling 
(slice-by-slice) 
3.0 yes A, MG, B MAD, DSC 3 
one based 
on two 
experts’s 
agreement 
Toth and 
Madabhushi [15] 
Landmark-free 
active appearance 
model 
3.0 yes 
WG, A, MG, B DSC 
108 
one for 108 
images and 
two for a 
subset of 
17 images 
WG MAD, DSC 
Liao et al. [16] Multi-atlas-based X X WG 
MAD, DSC, 
HD 
66 (test) 
9 (atlas) 
one 
Cheng et al. [107] Atlas-based 3.0 X WG 
TP, FN, FP, 
DSC, ΔV% 
100 
(training) 
40 (test) 
one 
Alvarez et al. [109] Atlas-based X 
24 out 
of 50 
WG DSC 50 one 
WG: whole gland, A: apex, MG: mid-gland, B: base 
1.7.3.2 Lack of a standard validation methodology 
Despite the lack of a straightforward gold standard, computer-assisted 
segmentation algorithms require validation to support clinical translation. This evaluation 
needs (1) a set of error metrics that are sensitive to different, clinically relevant types of 
contouring errors and (2) a method for evaluation of the contouring in different anatomic 
regions of interest within the prostate. The validation approach must take inter-observer 
variability in manual reference contours into account. To the best of our knowledge, there 
is no accepted standard set of error metrics use for evaluation of prostate contouring on 
medical imaging. Currently, most research groups have used one or two error metrics, 
and these choices have not generally been connected to any specific clinical procedures 
[1]. There are several classes of error metrics that have been used. In one class of metrics, 
the distances between corresponding points on the automatic and reference segmentations 
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are calculated and aggregated (e.g. the MAD). In another class of metrics, the overlap 
region of two shapes or volumes is measured in various ways (e.g. the DSC). However, 
each metric is able to detect one or few types of errors but not all different types of errors; 
e.g. local surface misalignment, partial regional overlap, and volume difference. 
Therefore, comprehensive segmentation algorithm evaluation requires a set of 
complementary error metrics that covers the range of errors types that are relevant to 
clinical procedures of interest. 
Furthermore, since the contouring is generally more challenging to perform (for 
both manual and automatic methods) at the inferior (apex) and superior (base) ends of the 
prostate, as compared to the midgland region, reporting the overall segmentation error for 
the whole prostate gland does not provide enough information about the local accuracy of 
the segmentation method under evaluation. Large errors in the base and apex can be 
compensated by small errors in the midgland, with an apparently favourable overall error 
reported that is discordant with large errors in the apex and base. Measuring segmentation 
errors separately within these different anatomic regions mitigates this issue. This helps 
the clinician to evaluate the readiness of an algorithm for clinical translation. 
1.8 Hypothesis 
The central hypothesis of this thesis is as follows: computer-assisted 3D prostate 
segmentation on T2w ER MRI will (1) decrease the time required for an expert physician 
to achieve a clinically acceptable segmentation, and (2) reduce inter-observer variability 
in segmentation, as compared to manual segmentation. 
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1.9 Objectives 
To test the central hypothesis, the three major objectives of this thesis are: 
I. (Chapter 2) To develop a semi-automatic prostate  segmentation 
algorithm for T2w prostate ER MRI, and evaluate it against multi-observer manual 
reference standard segmentations. 
II. (Chapter 3) To develop and evaluate a fully automated prostate  
segmentation algorithm for T2w prostate ER MRI, and evaluate it against multi-observer 
manual reference standard segmentation. 
III. (Chapter 4) To measure the inter-observer variability and total 
segmentation time resulting from the use of the semi-automatic (Objective I) and 
automatic (Objective II) segmentation methods, followed by expert manual editing to 
yield clinically acceptable segmentations. 
1.10 Thesis outline 
1.10.1 Chapter 2 - Spatially varying accuracy and reproducibility of prostate 
segmentation in magnetic resonance images using manual and semi-
automated methods 
The purpose of this work was to develop an approach for evaluation of a semi-
automatic prostate segmentation algorithm for T2w MRI acquired with an ER coil and 
compare it to manual segmentation in terms of accuracy and repeatability within the 
whole gland, and separately within the apex, mid-gland, and base regions. We collected 
MR images from 42 prostate cancer patients. The prostate border was delineated 
manually by one observer on all images and by two other observers on a subset of 10 
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images. We used complementary boundary-, region-, and volume-based metrics to 
elucidate the different types of segmentation errors that we observed. Compared to 
manual segmentation, our semi-automatic approach reduced the necessary user 
interaction by only requiring an indication of the anteroposterior orientation of the 
prostate and the selection of prostate center points on the apex, base, and midgland slices. 
Based on these inputs, the algorithm identified the prostate boundary using learned 
boundary appearance characteristics and performed regularization based on learned 
prostate shape information.  
In contrast with the active appearance model, our segmentation algorithm was 
based on local appearance characteristics. Furthermore, our algorithm optimized the 
segmentation first based on the appearance features and then further optimized based on 
shape features, rendering it more amenable to parallel computing implementation.  
The algorithm required an average of 30 seconds of user interaction time for each 
3D segmentation. Comparing the semi-automatic segmentations against a single-operator 
manual segmentation, the results of this chapter showed a MAD of 2.0 mm, DSC of 82%, 
recall of 77%, precision of 88%, and ΔV of = −4.6 cm3 for the whole gland on average. 
We found that overall, midgland segmentation was more accurate and repeatable than the 
segmentation of the apex and base, with the base posing the greatest challenge. The semi-
automatic approach reduced interobserver segmentation variability. Its accuracy, as well 
as the accuracies of recently published methods from other groups, were within the range 
of observed expert variability in manual segmentation. Further efforts in the development 
of computer-assisted segmentation would be most productive if focused on improvement 
of segmentation accuracy and reduction of variability within the prostatic apex and base. 
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1.10.2 Chapter 3 - Accuracy and acceptability of an automated method for 
prostate segmentation in magnetic resonance imaging 
In this chapter, we developed a fully automatic segmentation algorithm and 
evaluated its accuracy within different regions of interest (i.e. whole gland, apex, 
midgland, and base regions) using a complementary set of error metrics. We compared it 
to the semi-automatic approach (Chapter 2) and the inter-observer variability in manual 
segmentation. We used the same data set used in Chapter 2. In our automatic approach, 
we coarsely localized the prostate in the image using the prior measured dimensions of 
the gland that are readily available from the clinical TRUS examination before MRI 
acquisition. This localization is used to define the search space and to initialize the 
segmentation algorithm. Consequently, no user interaction is required for running the 
algorithm. 
We evaluated the algorithm using a set of region- bouandary- and volume-based 
metrics; i.e., MAD, DSC,  recall, precision and ΔV. We compared the accuracy of the 
automatic segmentation approach to the semi-automatic approach. We also compared the 
accuracy of both computer-assisted approaches to the range of inter-observer variation in 
manual segmentation. 
The automatic algorithm needed less than a minute to segment the prostate in 3D. 
Comparing the segmentation results to single-observer manual segmentation, for the 
whole gland we measured a MAD of 3.2 mm, DSC of 71%, recall of 69%, precision of 
76%, and ΔV of -3.6 cm3. In a multi-observer study, we measured a MAD of 3 mm, DSC 
of 72%, recall of 74%, precision of 74%, and ΔV of -0.3 cm3, whereas the difference 
between two observers’ manual segmentations were as high as MAD of 2.8 mm, DSC of 
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74%, recall of 87%, precision of 60%, and |ΔV| of 18.3 cm3. The results of the 
comparison of semi-automatic and automatic segmentation algorithm performance were 
mixed.  Overall, the previously presented semi-automatic approach outperformed the 
automatic approach in terms of most of the metrics within some of prostatic regions. 
However, there were some metrics such as recall and ΔV that revealed superior 
performance from the automatic approach on some prostatic regions, compared to semi-
automatic segmentation. 
The results of this chapter show that (1) concordant with results from other 
published algorithms, accuracy was highest in the mid-gland and lower in the apex and 
base regions of the prostate, (2) the fully automatic approach requires no user interaction 
and needs 3 seconds of computation time, (3) the differences between the automatic and 
semi-automatic segmentation error metrics were consistently smaller than the differences 
observed between manual contours performed by expert observers, (4) The segmentation 
error metric values were near to or within the range of expert manual segmentation 
variability for most of the metrics at most of the prostatic regions.  
1.10.3 Chapter 4 - Impact of physician editing on repeatability and time for 
manual and computer-assisted prostate segmentation on magnetic resonance 
imaging 
Segmentation of the prostate gland on T2w MRI is an important part of several 
diagnostic and therapeutic procedures for PCa. Since manual segmentation is time-
consuming and subject to high inter-expert operator variability, it has been widely 
recognized that these clinical procedures could benefit from a rapid and repeatable 
computer-assisted prostate segmentation technique. Many such algorithms have been 
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proposed in the literature [13-16, 107, 109], usually evaluated against manual reference 
segmentations performed by a single operator, with reported error metric values for 
recently published methods asymptotically approaching inter-operator variability in 
manual segmentation. Despite the tremendous volume of work performed in this area, the 
translation of computer-assisted segmentation algorithms to clinical care is rare, and 
manual segmentation is still routinely performed in clinic. As a step toward addressing 
this issue, in this chapter we focused on measuring the suitability of computer-assisted 
segmentation algorithms for clinical translation, based on measurements of inter-operator 
segmentation variability (which contributes to consistency of patient care) and 
measurements of the segmentation editing time required to yield clinically acceptable 
segmentations (which contributes to physician affinity to uptake of new segmentation 
tools, and patient throughput). We performed a pilot study with five expert operators 
under three pre- and post-editing conditions: manual segmentation, semi-automatic 
segmentation, and fully automatic segmentation. As expected, the results of this chapter 
showed that the amount of editing performed by the operators was directly related to the 
amount of automation involved in producing the starting segmentations. The provision of 
a starting segmentation using computer-assisted techniques reduced editing time and 
post-editing inter-operator variability, compared to manual segmentation. The amount of 
editing time was not correlated with the values of typically used segmentation error 
metrics such as the MAD between boundaries or the DSC, implying that the necessary 
post-segmentation editing time needs to be measured directly for multiple operators in 
order to evaluate an algorithm’s suitability for clinical translation. 
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Chapter 5 will conclude with a summary of the advances in knowledge stemming 
from this thesis work. This chapter also discusses the practical applications of this work 
and potential directions for future research. 
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Chapter 2. 
  
Spatially varying accuracy and reproducibility of 
prostate segmentation in magnetic resonance images 
using manual and semi-automated methods † 
 
2.1 Introduction 
PCa is the most common non-cutaneous cancer and was the second leading cause 
of cancer death among North American men in 2012 [1]. Three-dimensional (3D) 
prostate segmentation in medical images is useful to the planning of diagnosis and 
therapy procedures [2, 3]. Recent developments in magnetic resonance imaging (MRI) 
have demonstrated its usefulness for PCa detection and staging[4-6] with T2 weighted 
(T2w) MRI most commonly used for prostate boundary delineation due to its superior 
anatomic visualization [6]. Endorectal (ER) coil imaging provides improved image 
quality[4, 5, 7], but this coil induces substantial tissue deformation [8, 9] and the resulting 
higher contrast images contain more details and edges, presenting an increased challenge 
to segmentation algorithms designed for use on non-ER coil imaging. Manual 
segmentation of the prostate on MRI is a time-consuming task and is subject to 
                                                 
†A version of this chapter has been published: M. Shahedi, D. W. Cool, C. Romagnoli, G. S. Bauman, M. 
Bastian-Jordan, E. Gibson, G. Rodrigues, B. Ahmad, M. Lock, A. Fenster, A. D. Ward, “Spatially varying 
accuracy and reproducibility of prostate segmentation in magnetic resonance images using manual and 
semiautomated methods.” Medical Physics 41:11 (2014). 
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substantial inter-observer variation [10], motivating the need for a fast and reproducible 
segmentation algorithm for 3D segmentation of the prostate on T2W ER MRI. 
Several methods have been published in the literature for 3D segmentation of the 
prostate on T2W ER MRI. Martin et al. [11] presented a semi-automatic method based on 
the registration of an atlas to a test image using a combination of intensity-based and 
landmark-based methods, and evaluated it within different regions of interest including 
mid-gland, base and apex using a distance-based metric. They also used region-based 
evaluation for the whole gland. Vikal et al. [12] presented a semi-automatic slice-by-slice 
3D method using a shape model, evaluated on 3 images using the mean absolute distance 
(MAD) and Dice similarity coefficient [13] (DSC). Toth et al. [14] used a semi-automatic 
multi-feature landmark-free active appearance model, and selectively used the MAD and 
DSC for evaluation of different anatomic regions. Liao et al. [15]  presented an automatic 
multi-atlas-based segmentation method followed by a semi-supervised regularization. 
They evaluated their method using DSC, MAD and Hausdorff distance metrics on the 
whole gland. In 2012, a prostate MR image segmentation (PROMISE12) challenge was 
held as part of the Medical Image Computing and Computer Assisted Intervention 
(MICCAI) conference and involved 11 teams. This challenge compared the performance 
of the teams’ submitted prostate T2W MRI segmentation algorithms. It consisted of two 
main parts: an online challenge and a live challenge. The image data set in the challenge 
contained both ER and non-ER MR images, some acquired at 1.5 Tesla and some at 3.0 
Tesla magnetic field strengths. Four experts each manually segmented 25 images out of 
100 (i.e. each image was segmented by one expert and not more than one expert 
segmented each image). Next, an additional expert reviewed all the manual 
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segmentations and edited them for consistency as deemed necessary, yielding a single 
manual reference segmentation for accuracy measurement in each of the 100 cases (a 
second manual segmentation by an inexperienced non-clinical observer with two years’ 
experience in prostate MRI research was used for a ranking score calculation based on 
the error metrics, but was not used in any inter-operator variability measurements). The 
algorithms’ segmentations were compared with the manual reference using DSC, MAD, 
95% Hausdorff distance, and the percentage of the relative volume difference as the 
metrics. These metrics were reported on the whole gland, as well as the base and apex 
regions separately. The results of the live challenge on 20 images showed a range of  2.0 
mm to 4.2 mm for MAD, 65% to 89% for DSC, and 1.5% to 43.1% for absolute relative 
volume difference on whole gland [16].  
The PROMISE study measured the performance of different segmentation 
methods on the same set of images with the same manual reference. By holding the 
images and reference segmentations constant and measuring the performance of different 
algorithms, this study provided highly valuable measurements of variability in 
segmentation errors arising from the use of different state-of-the-art algorithms. By 
contrast, our study holds the algorithm constant (i.e. we tested a single algorithm) and 
used a reference standard based on multiple operators, addressing the question of the 
accuracy and variability of a segmentation algorithm’s results compared to inter-operator 
variability in the manual segmentation, such as one could observe in routine clinical 
practice. Thus, our study and the PROMISE study achieved complementary aims; in the 
future, a grand challenge-style study comparing different segmentation algorithms against 
a multiple-operator reference standard would be highly valuable. 
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In all of the reviewed published studies, the segmentation results were evaluated 
by comparison to a single-observer reference, with the inter-operator variability in 
manual segmentation and its effect on accuracy measurement not measured or taken into 
account in interpreting the segmentation results. In these studies, the accuracy was 
usually measured using one or at most two types of error metrics and none used a 
complementary set of error metrics capturing different types of errors such as 
surface/boundary misalignments, regional overlap errors, and volume differences. The 
use of a complementary set of error metrics is supportive of a comprehensive 
segmentation accuracy measurement, permitting the end user to focus on the metrics 
capturing performance aspects of importance to the user’s intended application of the 
technique. In addition, several previous studies report on segmentation accuracy only for 
the prostate gland as a whole, without reporting on spatial variations in the error through 
gland sub regions such as the apex, mid-gland and base. It is well-known that for both 
human experts and contemporary algorithms, mid-gland segmentation is usually 
performed with lower error and variability compared to segmentation of the apex and 
base, which are considered to be more challenging tasks. Thus, reporting of segmentation 
error on a whole-gland basis alone challenges the interpretation of the segmentation 
results in the interventional context, where accurate apex and base segmentations are 
critical to sparing harm to surrounding critical structures. 
To address the need for a 3D method, fully evaluated using a comprehensive set 
of metrics, we present here an interactive algorithm for 3D prostate segmentation on 
T2W ER MRI, based on learned local appearance of the prostate border and learned 
variability of prostate shape. We used a set of complementary boundary-based, overlap-
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based, and volume-based metrics to evaluate the segmentation over the whole gland and 
separately within each anatomic region of interest (prostate apex, mid-gland, and base). 
The method has two main steps, training and segmentation. During training, we captured 
the local image appearance of the prostate at the boundary on cross-sections from 
superior to inferior by computing a set of circular mean intensity image patches on each 
slice. The prostate shape variability on each axial slice was measured using a point 
distribution model (PDM) [17]. The segmentation algorithm requires minimal user input 
to initialize a radial-based search for candidate boundary points that are regularized using 
the PDM to produce the final result. The algorithm segmentations were validated against 
manual segmentations using complementary boundary-based (MAD), regional overlap 
(DSC, recall rate, and precision rate) and volume difference (ΔV) metrics, and inter-
operator variability was measured.  
2.2 Materials and Methods 
2.2.1 Materials  
We used 42 axial T2W fast spin echo ER MR images acquired as follows: 23 
images with TR = 4000–13000 msec, TE = 156–164 msec, NEX = 2 and 19 images with 
TR = 3500–7320 msec, TE = 102–116 msec, NEX = 1–2. Some images were acquired at 
1.5 Tesla (9 images) and some at 3.0 Tesla (33 images), with voxel sizes from 
0.27×0.27×2.2 mm to 0.44×0.44×6 mm (covering a range of voxel sizes typically seen in 
clinical prostate MRI). The images were acquired using four different scanners: Signa 
Excite, Discovery MR 750 (General Electric Healthcare, Waukesha, WI, USA), 
MAGNETOM Avanto, and MAGNETOM Verio (Siemens Medical Solutions, Malvern, 
PA, USA). All of the images were acquired from patients diagnosed with PCa based on 
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needle biopsy. The study was approved by the research ethics board of our institution, 
and written informed consent was obtained from all patients prior to enrolment. Each of 
the 42 images was segmented manually by one observer, with the segmentation 
subsequently reviewed and adjusted as deemed necessary by an expert radiology resident 
with experience in reading >100 prostate MRI cases. The initial manual segmentations 
were performed either by a radiologist or by a graduate student under the advisement of a 
radiologist. For inter-operator comparison, two additional observers (a radiologist and a 
radiation oncologist) each performed manual segmentations on a subset of 10 images to 
provide a total of three independent manual segmentations per patient. To select this 
subset of 10 images, we qualitatively assigned easy-, moderate- and difficult-to-segment 
labels to a set of images acquired at our institution, and randomly selected 10 images 
from all three categories. The prostate volumes were calculated based on the available 
manual segmentations for the whole image set and ranged from 15 cm3 to 89 cm3 with 
mean ± standard deviation (SD) of 35±14 cm3. 
2.2.2 Semi-automated segmentation  
Our algorithm consists of two main parts: training and segmentation. Figure 2.1 
shows the algorithm’s block diagram, illustrating the training and segmentation 
components, described in detail in sections 2.2.2.1 and 2.2.2.2 below. 
2.2.2.1 Training 
2.2.2.1.1 Spatial normalization. As a spatial normalization step, we parameterized the 
slice locations in the training images according to slices identified by the operator at 
specific anatomic locations. Our inferior-superior parameterization was from 0 (apex) to 
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1 (base) and was used to define inter-subject axial slice correspondence. Therefore, for 
each (𝑥, 𝑦, 𝑧) point in the MR Cartesian space, we have an (𝑥, 𝑦, ?̂?) point in the 
normalized coordinate system, where ?̂? is a real unitless value in the range of [0,1]. We 
map ?̂? values to corresponding slice numbers in the MR space by using a nearest 
neighbor inter-slice interpolation. We also chose the smallest physical pixel size along x- 
and y-axes (0.273 mm × 0.273 mm) in the data set as the reference pixel size and 
resampled all the training images with different pixel sizes to that reference pixel size, 
using bicubic interpolation. 
  
Figure 2.1: Algorithm block diagram. The training images are manually delineated. The 
candidate boundary points are shown on the test image after “border delineation” step. 
The final segmentation result is shown on the test image after the “3D regularization” 
step. 
2.2.2.1.2 Prostate border landmark selection. For each training image slice, we manually 
defined 4 corresponding landmark points on the prostate border: the anterior-most point, 
the opposite posterior point on the rectal wall, and two points approximately the 
midpoints of the portions of the prostate boundary touching the neurovascular bundles 
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(NVBs); see Figure 2.2. We used equal angle interpolation between each neighboring 
landmark pair, using the mid-point of the line segment defined by anterior and posterior 
landmarks as the central point, to define 32 additional landmarks, for a total of 36. For a 
slice with a parameterized axial position of ?̂?, the 𝑖th landmark is 𝒍𝑖,?̂? = (𝑥𝑖,?̂?, 𝑦𝑖,?̂?, ?̂?) and 
𝑖 ∈ {1,2, … ,36}. 𝑥𝑖,?̂? and 𝑦𝑖,?̂? are the x- and y-coordinates of the 𝑖
th landmark on the slice. 
We observed that in general, the anterior and NVB landmarks are separated by ~120 
degrees, and the NVB and posterior landmarks are separated by ~60 degrees. We 
therefore interpolated ~2/3 of the 32 additional landmarks between the NVB and anterior 
landmarks (11 interpolated landmarks on the left and right), and ~1/3 of the 32 additional 
landmarks between the NVB and posterior landmarks (5 interpolated landmarks on the 
left and right), as shown in Figure 2.2. 
2.2.2.1.3 Image patch. A circular image patch 𝒑(𝑚), centered at (𝑥𝜙, 𝑦𝜙, ?̂?) on the slice 
at axial position ?̂?, is defined as a vector of 𝑀 consistently ordered image intensities 
 𝒑 = Φ(𝑥𝜙, 𝑦𝜙, ?̂?) = {𝐼(𝑥, 𝑦, ?̂?)|𝐷((𝑥, 𝑦, ?̂?), (𝑥𝜙, 𝑦𝜙, ?̂?)) ≤ 𝑟𝜙}, (2.1) 
where 𝑟𝜙 is the patch radius, and 𝐷 is the  Euclidean distance function. 
2.2.2.1.4 Training image patches. We defined a circular image patch 𝒑𝑖,?̂? = Φ(𝒍𝑖,?̂?) =
Φ(𝑥𝑖,?̂? , 𝑦𝑖,?̂? , ?̂?), centered on 𝑖
th landmark of the 36 landmarks (𝒍𝑖,?̂?) in the training images. 
The intensity-normalized patch corresponding to the 𝑖th landmark on the 𝑘th training 
image (𝐼𝑘) is defined as 
 ?̂?𝑖,?̂?
𝑘 =
𝒑𝑖,?̂? − 𝝁𝝓
𝜎𝜙
, 
(2.2) 
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where 𝜇𝜙 and 𝜎𝜙 are the mean and standard deviation of 𝒑𝑖,?̂?, respectively. For each set 
of corresponding slices in the training set, we calculated the mean intensity of each 
corresponding set of patch pixels, yielding a set of 36 mean intensity patches. The mean 
intensity patch corresponding to the 𝑖th landmark at slice position ?̂? across the 𝑁 training 
images is defined as 
 ?̅?𝑖,?̂? =
1
𝑁
∑ ?̂?𝑖,?̂?
𝑘
𝑁
𝑘=1
 . 
(2.3) 
 
Figure 2.2: Training. determination of 36 prostate border landmarks. The four white dots 
are user-selected landmarks, the gray dots are interpolated landmarks, and the white cross 
is the origin. 
~120°
~60°
~120°
~60°
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2.2.2.1.5 Point distribution model. For each set of corresponding slices at slice position ?̂?, 
we also used the 36 landmarks to compute a PDM capturing prostate shape variability at 
each inferior-superior anatomic position. We used generalized Procrustes analysis[18] to 
align (translating, rotating and scaling) all the segmentations by minimizing the least 
squares error between the points. Principal component analysis was then used to compute 
the eigenvectors and eigenvalues of the covariance matrix for all of the training landmark 
coordinates[17]. 
2.2.2.2 Segmentation  
The segmentation algorithm incorporates a small set of inputs from the operator to 
define the inferior-superior extents of the prostate, as well as its center and orientation. 
These inputs are: (1) the apex-most and base-most slice numbers (𝑧); (2) the points at the 
center of the prostate on the apex- and base-most slices, and on the slice within the mid-
gland equidistant to these two slices; and (3) the anteroposterior (AP) orientation of the 
prostate as seen on this mid-gland slice. We developed a customized graphical user 
interface to efficiently collect these operator inputs. 
Using these operator inputs, we parameterized the axial slice positions of the test 
image as in training, permitting the extraction of the corresponding mean intensity 
patches and PDM corresponding to each axial slice from the training stage. The center 
points for all prostate slices were estimated by interpolating the three operator-provided 
center points on the base, mid-gland and apex slices. Therefore, a center point 
(𝑥𝐶(?̂?), 𝑦𝐶(?̂?), ?̂?) was available for each slice at position ?̂?. We approximated the 
orientation of the prostate in all axial slices from base to apex using the mid-gland AP 
symmetry axis (APSA). The segmentation was performed on each prostate axial slice 
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within the image volume, resulting in a 3D segmentation of the prostate from the base, 
through the mid-gland, to the apex. 
2.2.2.2.1 Preprocessing. Before delineating the prostate border, first we applied a median 
filter (using a 5 × 5 pixel sliding window) as an edge-preserving low-pass filter to each 
axial slice, in order to reduce image noise. 
2.2.2.2.2 Appearance-based boundary point selection. For each axial slice ?̂? in the 3D 
volume, we used the prostatic center point (𝑥𝐶(?̂?), 𝑦𝐶(?̂?), ?̂?) and the APSA to define 36 
rays emanating from the center point, intended to be homologous to the orientations of 
the training landmarks. We used a radial search strategy to choose a set of 36 candidate 
points for the prostate border on each slice. As the search space was small, we used an 
exhaustive search to maximize the normalized cross correlation (NCC) of each mean 
intensity patch with the image region under the patch along the corresponding ray (Figure 
2.3), i.e.: 
 (?̇?𝑖,?̂? , ?̇?𝑖,?̂?) = arg max
(𝑥,𝑦)
𝑁𝐶𝐶[?̅?𝑖,?̂?, Φ(𝑥, 𝑦, ?̂?)] , 
(2.4) 
 (𝑥, 𝑦) ∈ {(𝑥, 𝑦)|(𝑥, 𝑦, ?̂?) ∈ 𝑅𝑖, 𝑟𝑚𝑖𝑛 <  𝐷[(𝑥, 𝑦, ?̂?), (𝑥𝐶(?̂?), 𝑦𝐶(?̂?), ?̂?)] < 𝑟𝑚𝑎𝑥} , 
(2.5) 
where (?̇?𝑖,?̂?, ?̇?𝑖,?̂?) is the optimal point with the highest NCC along 𝑖
th ray (𝑅𝑖), 𝑟𝑚𝑖𝑛 and 
𝑟𝑚𝑎𝑥 indicate the search start point and stop point on each ray, respectively, and 
 𝑁𝐶𝐶(𝒑1, 𝒑2) =
1
𝑀
∑
𝒑1(𝑚) − 𝜇ϕ1
𝜎ϕ1
×
𝒑2(𝑚) − 𝜇ϕ2
𝜎ϕ2
𝑀
𝑚=1
 , 
(2.6) 
where 𝑀 is the number of pixels in patches 𝒑1 and 𝒑2, and  𝜇ϕ1 and 𝜇ϕ2 are mean voxel 
intensities, and 𝜎ϕ1 and 𝜎ϕ1 are the standard deviations of pixel intensities of patches 𝒑1 
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and 𝒑2, respectively. This process yielded 36 candidate border points on each slice, with 
one on each ray. 
2.2.2.2.3 Shape-based boundary regularization [two-dimensional (2D)]. We aligned the 
mean shape in the PDM to each set of 36 candidate points using Procrustes analysis and 
extracted the parameters from the model that represented the shape of the candidate 
points. Then we calculated the parameters of the nearest shape in the PDM to the 36 
candidate points by restriction of each extracted parameter in the model to the range of 
[−1.5𝜆, 1.5𝜆] where 𝜆 is the corresponding eigenvalue. We defined those points with 
absolute distances greater than 1.5 standard deviation to the nearest shape in the model as 
outlier boundary points, and corrected them by replacing them with the corresponding 
points of the model shape. This procedure was iterated until all outliers were eliminated 
or a specified maximum number of iterations was reached. This resulted in a set of shape-
regularized boundary points, yielding a plausible prostate shape. 
2.2.2.2.4 3D regularization. After applying two-dimensional (2D) shape regularization to 
all of the prostate slices, for ray i, a second order curve was fitted to all the boundary 
points from base to apex in order to regularize the prostate shape in 3D. By interpolating 
the points with a spline from apex to base, we obtained a smooth, continuous 3D 
segmentation of the prostate. 
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Figure 2.3: Segmentation. 36 rays and patch translation along one ray (the dotted manual 
segmentation is overlaid for reference but is not provided to the segmentation algorithm). 
2.2.3 Validation metrics  
We evaluated our method against manual segmentations with complementary 
boundary-based (MAD), regional overlap (DSC, recall and precision) and volume 
difference (ΔV) metrics. The metrics are explained later in this section. To develop a 
reference against which to compare the metrics resulting from our segmentation 
algorithm, we measured the inter-operator variability in expert manual prostate border 
delineation on a subset of 10 of our 42 3D images. Each of these images was manually 
segmented in 3D by three observers: one radiologist, one radiation oncologist, and one 
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radiology resident, all specializing in prostate MRI. We calculated the metrics (1) in 2D 
for each slice, (2) in 3D for the whole gland, (3) in 3D for the superior-most third of the 
prostate (corresponding approximately to the base), (4) in 3D for the middle third (mid-
gland), and (5) in 3D for the inferior-most third (apex). In cases where the operator’s 
selected apex and base slices differed from those of the reference segmentation, we 
calculated the 2D metrics on the slices that were common to both segmentations. To 
apply our 3D metrics to the defined base, mid-gland and apex regions, the middle third of 
the slices common to both the operator’s and the reference segmentations were defined as 
the mid-gland region, and the remaining inferior and superior parts were considered to be 
the apex-most and base-most components, respectively. The operator interaction time 
was measured as well as inter-operator time and accuracy differences.  
2.2.3.1 Mean absolute distance  
The mean absolute distance (MAD) is a metric that measures the disagreement 
between two curves (in 2D) or surfaces (in 3D) as an aggregate of Euclidean distances 
between corresponding sets of points on these surfaces. We defined two modes for 
computing the MAD: unilateral and bilateral. In unilateral MAD, one surface is the 
reference surface and points are corresponded by finding the closest point on the 
reference surface to each point on the other surface. The MAD is then the average of the 
distances between corresponding points, defined as 
 𝑀𝐴𝐷(𝑋, 𝑌) =
1
𝐾
∑ min
𝑞∈𝑌
𝐷(𝑝, 𝑞)
𝑝∈𝑋
 , 
(2.7) 
where X and Y are the point sets (Y is the reference set), K is the number of points of X, 
𝑝 = (𝑥𝑝, 𝑦𝑝, 𝑧𝑝) is a point in X and 𝑞 = (𝑥𝑞 , 𝑦𝑞 , 𝑧𝑞) is a point in Y, and 𝐷(𝑝, 𝑞) is the 3D 
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Euclidean distance between p and q. The bilateral MAD is defined as the mean of two 
unilateral MADs, calculated with each of the two surfaces as the reference. We reported 
𝑀𝐴𝐷 in mm, with 𝑀𝐴𝐷 =  0 mm indicative of perfect alignment between shapes, and 
larger 𝑀𝐴𝐷 values indicating increasing levels of shape disagreement. 
2.2.3.2 Dice similarity coefficient 
The Dice similarity coefficient (DSC) [13] measures the misalignment between 
two shapes in terms of their overlap region. The DSC of two 3D shapes is 
 𝐷𝑆𝐶(𝑋, 𝑌) =
2(𝑋 ∩ 𝑌)
𝑋 + 𝑌
=
2𝑇𝑃
𝐹𝑃 + 2𝑇𝑃 + 𝐹𝑁
 , 
(2.8) 
where TP is the true positive (correctly identified) region, and FN is the false negative 
(incorrectly ignored) region. We reported 𝐷𝑆𝐶 as a percentage. A 𝐷𝑆𝐶 value of 100% 
indicates perfect alignment, and a 𝐷𝑆𝐶 value of 0% indicates no overlap of the two 
shapes. 
2.2.3.3 Recall rate 
The recall rate, or sensitivity, is the proportion of the reference, which is 
identified correctly, defined as 
 𝑅𝑒𝑐𝑎𝑙𝑙(𝑋, 𝑌) =
𝑇𝑃
𝑇𝑃 + 𝐹𝑁
 . 
(2.9) 
In this chapter, 𝑅𝑒𝑐𝑎𝑙𝑙 is the proportion of the reference prostate segmentation that is 
within the segmentation provided by the algorithm and is reported as a percentage. An 
ideal 𝑅𝑒𝑐𝑎𝑙𝑙 value of 100% indicates that the segmentation provided by the algorithm 
covers the entire reference segmentation, plus potentially some additional regions outside 
of the reference segmentation. 
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2.2.3.4 Precision rate  
The precision rate is the proportion of the segmentation which is true positive, and 
is defined as 
 𝑃𝑟𝑒𝑐𝑖𝑠𝑖𝑜𝑛(𝑋, 𝑌) =
𝑇𝑃
𝑇𝑃 + 𝐹𝑃
 . 
(2.10) 
where FP is the false positive (incorrectly identified) region. In this chapter, 𝑃𝑟𝑒𝑐𝑖𝑠𝑖𝑜𝑛 is 
the proportion of the segmentation provided by the algorithm that is within the reference 
prostate segmentation. An ideal 𝑃𝑟𝑒𝑐𝑖𝑠𝑖𝑜𝑛 value of 100% indicates that the segmentation 
provided by the algorithm lies entirely within the reference segmentation, but may or may 
not completely overlap the reference segmentation. An ideal segmentation algorithm 
would yield 𝑃𝑟𝑒𝑐𝑖𝑠𝑖𝑜𝑛 of 100% and 𝑅𝑒𝑐𝑎𝑙𝑙 of 100%. Computing and interpreting these 
metrics both separately and together provides a means for understanding both the 
magnitude and the meaning of the types of regional overlap errors made by a 
segmentation algorithm, complementing the information provided by 𝐷𝑆𝐶. 
2.2.3.5 Volume difference (ΔV) 
The signed volume difference (ΔV) is the subtraction of the volume of the 
reference segmentation from the volume given by the segmentation algorithm: 
 ∆𝑉 =  𝑉𝑎𝑙𝑔𝑜𝑟𝑖𝑡ℎ𝑚 − 𝑉𝑟𝑒𝑓𝑒𝑟𝑒𝑛𝑐𝑒 , 
(2.11) 
where 𝑉𝑎𝑙𝑔𝑜𝑟𝑖𝑡ℎ𝑚 is the volume of segmentation result, and 𝑉𝑟𝑒𝑓𝑒𝑟𝑒𝑛𝑐𝑒 is the volume of 
the prostate in the manual segmentation. ΔV is a signed metric and was reported in cm3 in 
this chapter. A negative value of ΔV indicates under-segmentation and a positive value 
indicates over-segmentation in terms of the volume of the prostate.  
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2.3 Experiments 
For all of the experiments in this chapter, we used a single value for the patch 
radius 𝑟𝜙, chosen by systematic search. We selected a representative subset of 6 images 
from the data set. We applied our algorithm using patch radii in the range of 3 𝑚𝑚 ≤
𝑟𝜙 ≤ 17 𝑚𝑚, using leave-one-out cross-validation to define training and test images. For 
each image, we measured the MAD, DSC, ΔV, as well as the average of recall and 
precision values (as one metric) for each patch radius. Then, we calculated the average of 
the four metrics across the 6 images, yielding four mean values, one for each metric. We 
ranked the radii based on each metric, resulting in 4 rankings; thus, each radius had four 
rank values. We calculated the average of the 4 rank values for each radius and chose the 
radius (𝑟𝜙 = 5) having the lowest average rank. 
The radial search started on each ray from a distance of 2 mm from the center 
point (𝑟𝑚𝑖𝑛 = 2 𝑚𝑚) and ended at 35 mm (𝑟𝑚𝑎𝑥 = 35 𝑚𝑚). This range was chosen 
based on our observed prostate size and imaging field of view in the data set. The 
maximum number of iterations for shape-based 2D regularization was set to be 25. 
2.3.1 Inter-operator variability: Manual segmentation 
We compared the observers’ segmentations in a pairwise fashion using our 3D 
validation metrics. We also compared each observer’s segmentation to the simultaneous 
truth and performance level estimation (STAPLE) [19] segmentation derived from all 
three observers’ segmentations. STAPLE is a method that is intended to estimate a single 
reference segmentation from a set of reference segmentations using a weighted voting 
scheme. 
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2.3.2 Accuracy and Inter-operator variability: Semi-automatic segmentation 
We performed a single-operator evaluation of the semi-automated segmentation 
algorithm on all 42 3D images in our data set, and compared the results to a single 
manual reference segmentation. We used a leave-one-out cross-validation methodology 
to split the 42 images into training (41 images) and test (one image) sets in each of 42 
rounds of testing, with metrics averaged over all rounds. 
We performed a multiple-operator evaluation of the semi-automated segmentation 
algorithm in terms of accuracy, inter-operator variability, and operator interaction time. 
We partitioned our data set into non-overlapping training and test sets of 32 and 10 
images, respectively. The 10-image test set was the same as the data set used in Section 
2.3.1. Nine operators, including 4 radiation oncologists, one radiologist, one radiology 
resident, one imaging scientist and two graduate students, all with research and/or clinical 
experience with prostate imaging, used our semi-automated segmentation algorithm to 
segment each of the 10 images. We computed aggregate 3D segmentation metrics by 
averaging across all operators, and we also compared the metrics for each operator with 
all other operator results to measure the inter-operator variability. Since operators’ 
judgments regarding anteroposterior prostate orientation and the locations of the apex-
most and base-most slices differed, we measured the inter-operator variability in base and 
apex slice selection and prostate orientation definition. We calculated the mean standard 
deviation of the operators’ selected apex and base slice numbers, as well as the APSA 
angle with respect to anterior-posterior axis of the MRI coordinate system. To measure 
the inter-operator variability in apex, base and mid-gland center point selection, we first 
determined the superior-most (base) and inferior-most (apex) slices that were common to 
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the segmentations of all observers, as well as the mid-gland slice equidistant to both. We 
then calculated the means of the 9 actual or interpolated center points at each of these 
slice locations. On each slice, we then measured the Euclidean distance of each of the 9 
center points to the mean point. 
We had three manual segmentations available on the same 10-image test set as 
was used in Section 2.3.1. To perform a direct comparison of our segmentation error 
metrics for manual and semi-automatic segmentation, we used those three manual 
segmentations to compute a STAPLE reference standard segmentation from each of the 
10 images. Our error metrics were calculated with respect to the STAPLE reference for 
the manual segmentations, as well as for semi-automatic segmentations performed by the 
same experts on the same 10 images. The mean and standard deviation of these metrics 
for the manual and semi-automatic scenarios were calculated to measure differences in 
accuracy and observer variability arising from using manual vs. semi-automatic 
segmentation. 
2.3.3 Sensitivity to initialization: Semi-automatic segmentation 
To examine the sensitivity of the semi-automated segmentations to the operator’s 
center point selection, we performed a simulation study wherein our 42 images were 
repeatedly segmented 1000 times using perturbed (in accordance with the previously 
observed inter-operator variability) prostate center points at each iteration. We calculated 
perturbed center point positions within the prostate by randomly sampling from 2D 
Gaussian distributions (three in total: one for each of the apex, mid-gland, and base 
slices) with means defined at “ideal” center points defined on the midpoint of the line 
segment between the most-anterior and the most-posterior prostate border landmarks 
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used in the training. The standard deviations of these Gaussian distributions were 
estimated based as the root mean square (RMS) distances to the means of the center 
points collected from the nine operators in Section 2.3.2. In this test, the sensitivity for 
each image was measured as the difference of the metrics based on the perturbed center 
points and the metrics based on the “ideal” center points. Therefore, for N images and 
1000 repetitions, we have 1000N measured differences. We reported the mean and the 
standard deviation of these 1000N values for each metric. 
To measure the sensitivity of the results to the selection of the anteroposterior 
symmetry axes, we performed another simulation study wherein our 42 images were 
repeatedly segmented 1000 times using randomly modified axis angles. For that purpose, 
at each iteration, we randomly selected a set of 42 angles from a Gaussian distribution 
with zero mean and the same standard deviation as the standard deviation of the observed 
angle across the nine operators in Section 2.3.2, and added them to the symmetry axis 
angles used in the single-operator experiment. We measured the sensitivity as the 
differences between metrics based on the randomly generated angles and the metrics 
based on the reference angles used in the single-operator experiment. We reported the 
mean and standard deviation of these differences across all patients and 1000 repetitions. 
2.3.4 Source of Variability: Semi-automatic segmentation 
To measure the relative contributions of different sources of variability for our 
semi-automatic segmentation algorithm, we designed a three-way analysis of variance 
(ANOVA) test, with reference, trainer, and operator factors. We used the same subset of 
10 images as used in the three-operator experiment, and two observers (denoted Observer 
#1 and Observer #2) who were selected due to the discordance of their manual 
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segmentations of these 10 images observed in the results of experiment described in 
Section 2.3.1. These two observers also executed the semi-automated segmentation on 
each of these 10 images. For these two observers, all possible configurations of manual 
segmentations used for reference (used to calculate the validation metrics), manual 
segmentations used as the trainers for the semi-automated tool, and semi-automated 
segmentation operators were tested. This yielded a set of segmentation error metrics for 
each configuration. We performed an ANOVA test for each of our five metrics and each 
region of interest including whole gland, mid-gland, base and apex to test the following 
null hypotheses: 
H01: The trainer has no significant impact on the error. 
H02: The operator has no significant impact on the error. 
H03: The reference has no significant impact on the error. 
2.4 Results 
2.4.1 Inter-operator variability: Manual segmentation 
The key result of this experiment was a substantially high inter-operator 
variability in manual segmentation. Table 2.1 shows the range of 3D metrics in pair-wise 
comparison between operators and also between each operator and STAPLE reference. 
Since in this experiment, the segmentations in each pair-wise comparison were both 
performed manually, the MAD values were calculated in bilateral mode and the absolute 
volume difference (|∆𝑉|) was calculated. MAD values were calculated in unilateral mode 
with STAPLE as the reference, and the signed volume difference (∆𝑉) was reported. 
Figure 2.4 qualitatively shows the inter-observer variability in prostate segmentation. 
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Table 2.1: Inter-operator variability in manual segmentation: Range of mean MAD, 
DSC, recall, precision, and ΔV (bilateral MAD and |ΔV| was used for “Operator vs 
Operator” section). 
  Range of mean metric values 
 
Region of interest MAD (mm) DSC (%) Recall (%) Precision (%) ΔV (cm3) 
Operator vs 
Operator 
Whole gland [1.0,2.8] [74,90] [87,99] [60,94] [1.9,18.3] 
Mid-gland  [0.7,1.8] [88,96] [96,99] [81,95] [0.1,3.3] 
Apex  [1.1,3.0] [65,88] [83,98] [51,94] [0.5,6.1] 
Base  [1.3,3.5] [66,86] [79,99] [52,93] [1.5,7.7] 
Operator vs 
STAPLE 
Whole gland [0.2,3.1] [78,98] [66,100] [87,98] [-2.8,15.5] 
Mid-gland  [0.2,1.9] [89,98] [82,100] [96,99] [-0.5,3.2] 
Apex  [0.2,3.4] [70,99] [58,100] [84,98] [-0.8,5.3] 
Base  [0.2,3.7] [72,98] [60,100] [80,98] [-1.8,7.0] 
 
  
Figure 2.4: Inter-observer variability. The 3D surfaces show the three manual 
segmentations and the algorithm results. The three solid contours show the three 
observers’ manually drawn contours. The dashed contours show the algorithm’s results. 
2.4.2 Accuracy and inter-operator variability: Semi-automatic segmentation 
The key results of this experiment were that (1) the accuracy measured for our 
algorithm based on one reference, similar to the accuracies of most of the other 
segmentation algorithms presented in the literature, are within the inter-operator 
variability range for manual segmentation on our data set; (2) the variability observed 
between different operators in the measured errors using a multi-operator study was not 
significant based on most of the metrics and for most regions of interest. The results of 
the single-operator evaluation of the semi-automated segmentation algorithm on all 42 
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3D images in our data set are shown in Table 2.2 and compared to previous work. For the 
whole gland, we measured a mean±standard deviation MAD (unilateral) of 2.0±0.5 mm, 
DSC of 82±4%, recall of 77±9%, precision of 88±6% and ΔV of -4.6±7.2 cm3. The 
measured mean±standard deviation execution time using an unoptimized Matlab research 
platform on a single CPU core was 85±20 sec. Under the assumption of normal 
distribution of the error metric values, we conducted one-tailed heteroscedastic t-tests 
[20] to compare our results to previous work, in each case testing the null hypothesis 
regarding the relative performance of the methods. With α=0.05, corresponding letters 
show where the null hypothesis was rejected in Table 2.2. Figure 2.5 shows qualitative 
and quantitative results for three sample prostates. 
Table 2.2: Accuracy and variability for semi-automatic segmentation: mean±standard 
deviation of MAD, DSC, recall, precision, and ΔV. Corresponding letters show 
statisticaly significant differences between each error value of our method and the 
corresponding error value of another method where applicable. (p < 0.05). 
Methods N Region of interest MAD (mm) DSC (%) Recall (%) Precision (%) ΔV (cm3) 
Our method  42 
Whole gland 2.0±0.5 bi 82±4 ac 77±9 m 88±6 n -4.6±7.2 
Mid-gland (1/3) 1.6±0.5 j 90±3d 90±7 91±6 -0.1±2.0 
Apex (1/3) 2.0±0.7 gk 79±6 e 82±14 80±13 0.1±3.3 
Base (1/3) 2.6±0.8 l 73±10 fh 61±14 93±6 -4.5±3.7 
Liao et al [15] 66 Whole gland  1.8±0.9 88±3 a - - - 
Toth et al [14] 108 
Whole gland 1.5±0.8 b 88±5 c - - - 
Mid-gland (1/3) - 91±4 d - - - 
Apex (1/3) - 84±9 e - - - 
Base (1/3) - 88±6 f - - - 
Vikal et al [12] 3 
Mid-gland (9/13) 2.0±0.6 93±3 - - - 
Apex (2/13) 3.8±0.9 g 80±5 - - - 
Base (2/13) 3.9±1.8 86±8 h - - - 
Martin et al 
[11] 
17 
Whole gland 3.4±2.0 i - 89±6 m 78±12 n - 
Mid-gland 2.4±1.3 j - - - - 
Apex 2.9±1.3 k - - - - 
Base 4.3±2.0 l - - - - 
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 W.G. M.G Apex Base 
MAD 
(mm) 
1.7 1.3 1.3 2.1 
DSC 
(%) 
85 92 85 80 
Recall 
(%) 
84 97 83 73 
Precision 
(%) 
87 88 86 87 
ΔV 
(cm3) 
-1.3 1.4 -0.2 -2.5 
 
 
 
 W.G. M.G Apex Base 
MAD 
(mm) 
1.8 1.2 1.8 2.4 
DSC 
(%) 
82 92 80 75 
Recall 
(%) 
79 96 98 61 
Precision 
(%) 
86 88 68 99 
ΔV 
(cm3) 
-2.4 0.9 2.4 -5.6 
 
 
 
 W.G. M.G Apex Base 
MAD 
(mm) 
2.2 1.7 2.3 2.4 
DSC 
(%) 
85 91 83 82 
Recall 
(%) 
84 89 97 71 
Precision 
(%) 
86 93 73 97 
ΔV 
(cm3) 
-0.9 -0.5 3.2 -3.6 
 
Figure 2.5: Qualitative and quantitative results for three sample prostates. In the left 
column, the semi-transparent surfaces show the manual segmentation as reference, and 
the solid surfaces show the algorithm results. On the 2D cross sections, the manual 
segmentation is shown with a solid line, and the algorithm’s segmentation is shown with 
a dashed line. The most inferior and the most superior slices that contain both reference 
and algorithm contours were, respectively, shown as the apex and base. In the right 
column, the tables show the measured error metrics for that corresponding cases in whole 
gland (W.G.), as well as apex, mid-gland (M.G.), and apex. 
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For our multiple-operator evaluation of the semi-automated segmentation, Figure 
2.6 shows the results for each of the 9 operators in comparison with STAPLE. The 
average interaction time across 9 operators and 10 images was measured as 28±14 sec. 
To determine whether there are significant differences between the means of the error 
metrics for each operator we conducted one-way ANOVA followed by Bonferroni’s 
pairwise tests with the null hypothesis that the means of the metrics for all the 9 operators 
were the same. We showed the post ANOVA test results in Figure 2.6 for each region of 
interest, where ANOVA detected significant inter-operator differences in terms of any of 
the metrics (α=0.05). Table 2.3 also shows the average results across all 9 operators and 
10 images and compares it to the results based on one operator on 42 images reported in 
Table 2.2. For each metric, we applied a t-test with the null hypothesis that the means of 
the metric resulting from the 9 operators’ segmentations of 10 images are the same as the 
mean of the metric for one operator’s segmentation of 42 images (i.e. comparing the top 
row of Table 2.3 to the bottom row, for each metric and within each anatomic region) . 
Table 2.3: The average results across the nine operators and 10 images compared to the 
single operator results across 42 images: mean±standard deviation of MAD, DSC, recall, 
precision,  and ΔV. Corresponding letters indicate statistically significant differences 
between two modes (p < 0.05). 
Methods N Region of interest MAD (mm) DSC (%) Recall (%) Precision (%) |ΔV| (cm3) 
One operator 
(Table 2.2) 
42 
Whole gland 2.0±0.5 82±4 b 77±9 d 88±6 -4.6±7.2 
Mid-gland  1.6±0.5 90±3 90±7 91±6 -0.1±2.0 
Apex  2.0±0.7 79±6 82±14 80±13 0.1±3.3 
Base  2.6±0.8 a 73±10 c 61±14 e 93±6 -4.5±3.7 
Nine operators 10 
Whole gland 2.2±0.7 77±8 b 72±12 d 86±10 -4.0±5.5 
Mid-gland  1.7±0.7 89±4 88±8 91±7 -0.1±1.7 
Apex  2.0±1.0 78±12 84±15 78±17 0.6±3.3 
Base  2.9±0.8 a 65±12 c 54±17 e 92±11 -4.5±3.4 
 
For each image, the apex and base slices were manually selected by each of the 9 
operators. We calculated the resulting standard deviation of the slice positions for each 
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image and obtained their average across all 10 images. The mean standard deviation of 
the operators' selected apex and base slices were 1.8 slices (4 mm) for the apex and 1.3 
slices (2.9 mm) for the base. The range of the maximum inter-operator difference at the 
apex was 3 to 9 slices (6.6 mm to 19.8 mm) with a mean of 5.7 slices (12.5 mm), and this 
range for base was 2 to 10 slices (4.4 mm to 22 mm) with a mean of 3.8 slices (8.4 mm). 
The mean standard deviation of the APSA angle with respect to anteroposterior axis of 
the MRI coordinate system was 3.2 degrees. The differences between operators ranged 
from 4.0 to 17.8 degrees with a mean of 9.8 degrees. 
For the center points, the measured distances ranged from 0 mm to 3.9 mm with 
an average of 1.1 mm at the apex, 0.2 mm to 4.3 mm with an average of 1.3 mm at the 
mid-gland, and 0.1 mm to 4.9 mm with an average of 1.7 mm at the base. The RMS of 
the point distances were 1.3 mm, 1.5 mm, and 2.0 mm at the apex, mid-gland and base, 
respectively. The actual range of distances by which the center points were perturbed 
were [-5 mm, +5mm], [-7 mm, +7 mm], and [-8 mm, +8 mm] for the apex, midgland, and 
base, respectively. 
Table 2.4 shows the of manual and semi-automatic segmentations performed by 
the same three operators on 10 images. 
Table 2.4: Consistency of the manual and the semi-automatic segmentations: average of 
means (average of standard deviations) of MAD, DSC, recall, precision,  and ΔV across 3 
manual and 3 semi-automatic segmentations of the prostate by 3 expert operators. 
 
N Region of interest MAD (mm) DSC (%) Recall (%) Precision (%) ΔV (cm3) 
Manual 
segmentation 
10 
Whole gland 1.3 (1.6) 90 (11) 88 (19) 94 (6) 3.9 (10.1) 
Mid-gland  0.8 (0.9) 95 (5) 93 (10) 97 (2) 0.8 (2.1) 
Apex  1.4 (1.8) 86 (15) 85 (24) 93 (8) 1.4 (3.3) 
Base  1.6 (1.9) 86 (14) 86 (22) 91 (11) 1.6 (4.8) 
Semi-automatic 
segmentation 
10 
Whole gland 1.9 (0.3) 80 (4) 75 (7) 88 (3) -3.2 (2.9) 
Mid-gland  1.5 (0.3) 90 (2) 90 (3) 91 (2) 0.2 (0.7) 
Apex  1.8 (0.4) 82 (4) 87 (8) 80 (8) 0.8 (1.2) 
Base  2.7 (0.5) 68 (7) 57 (12) 93 (6) -4.2 (2.5) 
 
79 
 
  
  
 
Figure 2.6: Inter-observer variability. Mean±standard deviation (a) MAD, (b) DSC, (c) 
recall, (d) precision, and (e) V for each of the 9 operators for whole gland (W.G.), apex, 
mid-gland (M.G.), and base (P < 0.05). The last two columns in each section show the 
average variations of the metric using perturbed prostate center point, and anteroposterior 
symmetry axes, respectively. 
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2.4.3 Sensitivity to initialization: Semi-automatic segmentation 
The key result of this experiment was that the sensitivity of the algorithm 
accuracy to center point and anteroposterior symmetry axis selection was substantially 
lower than the measured error metric values. The means and standard deviations of the 
variation of metrics with regards to center point and anteroposterior symmetry axes 
variations are shown in Figure 2.6 for the whole gland as well as apex, mid-gland, and 
base regions. 
2.4.3.1 Sensitivity to centre point selection 
For the whole gland, the mean and the range of variation ([minimum, maximum]) 
for MAD, DSC, recall, precision and ΔV, respectively, were 0.1 mm ([-1.3 mm, 2.0 
mm]), -1% ([-24%, 11%]), -1% ([-33%, 16%]), -1% ([-19%, 16%]), and -0.2 cm3 ([-18.4 
cm3, 15.4 cm3]). The mean and standard deviation of the differences between results 
based on randomly generated center points and reference center points across 42 patients 
and 1000 repetitions are shown in Table 2.5. 
2.4.3.2 Sensitivity to anteroposterior symmetry axes selection 
For the whole gland, the mean and the range of variation ([minimum, maximum]) 
for MAD, DSC, recall, precision and ΔV, respectively, were 0.0 mm ([-0.7 mm, 0.9 
mm]), 0% ([-8%, 5%]), 0% ([-15%, 8%]), 0% ([-11%, 8%]), and -0.2 cm3 ([-9.2 cm3, 4.5 
cm3]). Table 2.5 shows the mean and one standard deviation of the differences between 
results based on randomly generated angles and the reference measurements across 42 
patients and 1000 repetitions. 
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Table 2.5: Sensitivity of the semi-automatic algorithm to initialization (center points and 
anteroposterior symmetry axes): mean±standard deviation of MAD, DSC, recall, 
precision,  and ΔV offsets from reference measurements across 1000 repetitions × 42 
patients. 
 
N # of Iterations Region of interest MAD (mm) DSC (%) Recall (%) Precision (%) ΔV (cm3) 
Sensitivity to 
center point 
selection 
42 1000 
Whole gland 0.11±0.30 -1.0±2.6 -1.3±3.8 -0.7±2.6 -0.2±2.0 
Mid-gland  0.14±0.44 -1.1±3.0 -1.4±4.5 -0.6±3.0 -0.1±1.0 
Apex  0.09±0.39 -0.9±3.2 -1.0±3.4 -0.7±4.7 0.0±0.8 
Base  0.09±0.41 -1.2±4.4 -1.3±6.0 -0.8±3.4 -0.1±1.1 
Sensitivity to 
anteroposterior 
symmetry axes 
selection 
42 1000 
Whole gland 0.02±0.15 -0.3±1.2 -0.4±2.0 -0.1±1.7 -0.2±1.1 
Mid-gland  0.03±0.19 -0.2±1.2 -0.4±2.3 0.0±2.0 0.0±0.6 
Apex  0.00±0.23 -0.1±1.9 -0.2±2.3 0.1±3.0 -0.1±0.6 
Base  0.04±0.22 -0.4±2.4 -0.5±3.6 0.0±1.9 -0.1±0.6 
 
2.4.4 Source of variability: Semi-automatic segmentation 
The key result of this experiment was that the operator has less impact on the 
algorithm accuracy, as compared to the reference and trainer. For all of the null 
hypotheses tested by ANOVA, rejection was reported at the p < 0.05 level. For the mid-
gland, there was a significant effect of the trainer on all the metrics and reference had a 
significant impact on three of the metrics (ΔV, recall, and precision). There was no 
significant impact of the operator on the metrics. For the apex, the reference had a 
significant impact on 4 of the metrics (DSC, ΔV, recall, and precision) and the trainer and 
operator had no significant impact on the metrics. For the base, the reference had a 
significant impact on all of the metrics, the operator had significant impact on four 
metrics (DSC, ΔV, recall and precision) and the trainer had significant impact on two 
metrics (recall and precision) and a marginally significant (p < 0.1) impact on DSC. 
2.5 Discussion  
In the presented semi-automatic segmentation algorithm, we first trained our 
algorithm to capture the inter-patient local appearance of the prostate border as well as 
the prostate shape characteristics on different axial cross-sections. Then for an unseen 
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MR image, the prostate border was locally defined based on the learned appearance 
characteristics of the prostate border at the corresponding location. The defined border 
was regularized on each 2D axial slice using the corresponding 2D shape model obtained 
from training. Finally, a 3D shape regularization was applied to the result. In the 
statistical modeling method referred to as an active appearance model [21], the global 
appearance of the image is used in combination with the shape model of the prostate to 
segment the prostate. Therefore, an inter-patient internal appearance variation of the 
prostate gland that could be caused e.g. by differently-located prostate tumours or benign 
prostatic hyperplasia nodules challenges the segmentation. Furthermore, using the 
combination of the shape and appearance modeling challenges the simultanous shape 
modeling when there is a local appearance difference between the test image and the 
appearance model. We addressed this issue by separating the shape model from the 
appearance based segmentation.  
2.5.1 Inter-operator variability: manual segmentation 
We observed substantial inter-operator variability in manual segmentation of the 
prostate on T2W ER MRI (Table 2.1), with differences between operators ranging 
between 0.7 mm and 3.5 mm in terms of MAD, and between 65% and 96% in terms of 
DSC, depending on the observer pair and the anatomic location. There was more inter-
operator consistency in delineation of the mid-gland, with greater discordance at the apex 
and base. These results suggest that measured errors for prostate segmentation algorithms 
on T2W ER MRI may vary substantially as a function of the manual segmentation used 
as the reference. Therefore, it is challenging to define a “gold standard” for this task. 
Consequently, segmentation results reported for an algorithm using a single-operator 
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reference may change substantially if a different operator were to delineate a set of 
reference segmentations on the same data set. This inter-observer variability also renders 
comparison of algorithm performance challenging when different data sets and reference 
segmentations are used in different published results. One approach to mitigate this effect 
is to evaluate algorithm performance against multiple expert reference segmentations, 
and assess the algorithm’s segmentation error in the context of inter-operator variability 
in manual segmentation on the same data set. 
2.5.2 Accuracy and inter-operator variability: Semi-automatic segmentation 
For comparison with previous work, we conducted a single-operator, single-
reference experiment measuring the accuracy of our presented semi-automatic 
segmentation algorithm. Some statistically significant differences were found with 
respect to other published methods (Table 2.2) but were within the observed ranges of 
human expert variability in manual delineation on our data set (Table 2.1). Concordant 
with previously published results, our data show that segmentation of the apex and 
(especially) the base is considerably more challenging than the segmentation of the mid-
gland, with errors contributed not only by the unusual shape and appearance of these 
structures in some patients (e.g. the shape of the base on the manual segmentation shown 
in the right-hand panel of Figure 2.4), but also by the substantial variability we measured 
in experts’ selections of the apex-most and base-most slices. Our results in Table 2.2 
compare favorably with many of the segmentation error metric values reported from the 
PROMISE12 challenge [16]; however, the different nature of the data sets in terms of ER 
coil usage challenges the interpretation of this comparison. For the prostate as a whole, 
our algorithm and the top performing algorithms in PROMISE12 appear to be 
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asymptotically approaching human performance as reflected by inter-observer variability 
in manual contouring. These observations suggest that further improvement of algorithms 
for computer-assisted segmentation of the mid-gland are unlikely to provide measurable 
impact, and that efforts toward improved accuracy and consistency in prostate apex and 
base segmentation are a higher priority. Informal observations of our results suggest 
negligible impact of magnetic field strength on segmentation error; however, this would 
be an interesting area of future research on a larger data set of 1.5 Tesla and 3.0 Tesla 
images. 
We observed maximum inter-operator differences in apex-most and base-most 
slice selection of 12.5 mm at the apex and 8.4 mm at the base on average; these represent 
aggregates of the largest distances one might observe between these observers’ apex and 
base-most slices, respectively. On the other hand, when the mean surface-to-surface 
distances (i.e. the MAD values) were calculated for the same nine observers using the 
semi-automatic algorithm (Table 2.3) and for a subset of three of the observers doing 
manual contouring (Table 2.1), smaller values (~2–4 mm) were observed. Although the 
mean surface-to-surface distances would be expected to be smaller than the measured 
maxima (as observed), the magnitudes of the observed differences in our data suggest 
that the bulk of the surfaces at the apex and base are in better spatial agreement than are 
the extrema of the prostate, which cover a relatively smaller surface area and thus have 
less influence on the calculated MAD metric values. Thus, there appear to be spatial 
differences in terms of where most of the inter-observer variability lies; there is greater 
variability in localizing the superior-most end of the apex and inferior-most end of the 
base, compared to the variability in contouring the apex and base as a whole. 
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Although our use of signed prostate volume differences as well as recall and 
precision rates as complementary evaluation metrics is unusual with respect to previously 
published work in this area, these metrics can be helpful in distinguishing different types 
of segmentation errors in a way that could facilitate the understanding the clinical 
applicability of the algorithm and facilitate adoption. For instance, in the lower-most 
segmentation shown in Figure 2.5, the algorithm over-contours the apex and under-
contours the base overall. These two errors are quite different in terms of potential 
clinical impact; for example, in a radiation oncology context, under-contouring could 
result in untreated cancer whereas over-contouring could result in radiation damage to 
surrounding healthy tissue. The table adjacent to this example in Figure 2.5 indicates that 
the MAD and DSC metrics, frequently reported in previous literature, are nearly identical 
for the apex and base. However, for the apex, recall is substantially larger than precision, 
and vice-versa for the base, capturing the nature of this segmentation error. The ΔV 
metric also directly captures this error in a complementary fashion. 
Our nine-operator experiment resulted in small degradations of accuracy (Table 
2.3), although the results were still within the range of expert variability in manual 
segmentation (Table 2.1). Our three-operator experiment directly comparing 
segmentation error and variability for manual and semi-automated segmentation of the 
same 10 images compared to the same STAPLE reference standard indicated an increase 
in error with a concomitant decrease in variability when the semi-automated tool was 
used. This suggests the presence of a tradeoff between segmentation accuracy and 
variability that is related to the use of automation; computer-assisted delineation may 
increase the consistency of segmentations at the expense of some accuracy. This lost 
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accuracy could in principle be recovered through minor segmentation editing, but this 
remains to be tested. The observed reduction in segmentation variability also suggests 
that the semi-automatic segmentation tool could be valuable in the hands of the novice 
radiologist or radiation oncologist, providing useful guidance in the form of a 
segmentation that is consistent with a training set constructed based on segmentations 
provided by experienced experts. 
2.5.3 Sensitivity to initialization: Semi-automatic segmentation 
Our data indicate that variability in the semi-automatic segmentation results 
arising from varying the inputs to the algorithm (Table 2.5) is substantially smaller than 
the segmentation accuracy and variability observed for both manual and semi-automatic 
segmentation. This suggests that the algorithm is robust to the placement of center points 
and orientation of the gland by the user, and helps to explain the accuracies we obtained 
despite minimal user interaction; users do not need to exercise a high degree of time-
consuming accuracy and precision in interacting with this tool. Moreover, since the 
prostate APSA is very close to the image AP axis, it might be possible to replace it with 
the image AP axis and minimize the user interaction without loss of accuracy. 
2.5.4 Source of variability: Semi-automatic segmentation 
Our ANOVA test results indicated that in all regions of the prostate, the reference 
segmentation used for evaluation had the most significant impact on segmentation error. 
This reinforces our earlier observation (Section 2.5.1) that measurements of a 
segmentation algorithm’s performance based on single reference segmentation could vary 
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substantially according to the particular expert reference segmentation used for 
evaluation. 
With the exception of the base region, our test did not detect a significant impact 
of the operator on any of the error metrics. This suggests that the use of the proposed 
semi-automated segmentation tool could result in improved inter-operator consistency of 
mid-gland and apex delineations, but that further work would be useful to improve the 
consistency of delineation of the challenging area of base, where the prostate meets the 
bladder neck. 
The significant impact of the trainer on all the metrics (within the mid-gland), in 
conjunction with the above observation regarding the impact of the operator, suggests 
that in this region the semi-automatic segmentation algorithm might provide outputs that 
mimic the trainer more than the operator. Hence, this tool could be useful in the hands of 
an expert trainer and a relatively more novice operator. Further work involving a larger 
sample size will be required to elucidate the impact of the trainer on the apex and base 
regions. 
2.5.5 Limitations 
The results of this work must be considered in the context of its strengths and 
limitations. To the best of our knowledge, this work represents the first use of the 
complementary MAD, DSC, recall, precision and ΔV error metrics in the evaluation of a 
prostate segmentation algorithm for T2W ER MRI, using multiple operators and multiple 
reference standard segmentations. However, our study was limited in several ways. First, 
our sample size (42 images for the single-operator experiment and 10 images for the 
multiple-operator experiment) is small and therefore the results of this study should be 
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considered to be hypothesis-generating, and our conclusions should be interpreted 
accordingly. Second, the only MR appearance information used by our segmentation 
algorithm to delineate the border is MR image intensity; no derived quantities such as 
image texture measures were utilized. Although using such features may add complexity 
and computation time to the method, such an approach could yield improved results, 
especially in the context of high variability of shape of the base and apex where our shape 
regularization step is less applicable. Third, we did not provide the operators with the 
opportunity to edit the semi-automatic segmentations to their satisfaction; an interesting 
avenue of further work would be to measure the time required for the user to obtain a 
satisfactory segmentation using the output of the semi-automatic tool as a starting point. 
Finally, since all of the images in our data set are from patients with confirmed PCa, the 
appearance of the prostate could have been locally modified in the presence of lesions 
near the capsule, increasing the challenge of accurate prostate segmentation using a local 
model of appearance; thus, our patient selection may have pessimistically affected our 
reported semi-automatic segmentation results. 
2.5.6 Conclusions 
We presented a comprehensive evaluation of a 3D segmentation algorithm for 
prostate T2W ER MRI, comprising boundary-, region-, and volume-based metrics 
computed separately for the whole gland, mid-gland, apex and base. We tested the 
algorithm using multiple reference segmentations and multiple operators, and observed 
reduced inter-operator variability via the use of this semi-automated tool. Minimal 
operator interaction of less than 30 sec, on average, was required. Based on our results, 
further work in this area should be focused on improving segmentation accuracy and 
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variability at the prostatic base and apex, including reducing inter-observer variability in 
selecting the apex-most and base-most slices of the prostate. Due to high inter-operator 
variability in the manual prostate segmentation, particularly at the apex and base, it 
appears to be challenging to interpret reported improvements in segmentation algorithm 
accuracy based on a single-operator manual reference standard. We anticipate that our 
comprehensive approach to segmentation evaluation will facilitate the assessment and 
adoption of our algorithm by clinical end users, who can interpret the segmentation 
metrics as appropriate to their clinical use cases of interest. 
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Chapter 3. 
  
Accuracy and acceptability of an automated method for 
prostate segmentation in magnetic resonance imaging † 
 
3.1 Introduction 
Prostate cancer (PCa) is the most commonly diagnosed cancer in men in North 
America, excluding skin carcinoma. More than 30,000 deaths from PCa are predicted in 
the United States and Canada for 2015 [1, 2]. Magnetic resonance (MR) imaging (MRI), 
due to its promising potential in diagnosis and staging of PCa [3, 4], is one of the imaging 
modalities utilized in multiple emerging diagnosis and therapeutic procedures. 
Contouring of the prostate on MRI could assist with PCa diagnosis and therapy planning. 
More specifically, T2-weighted (T2w) MRI is superior to other MRI sequences for 
anatomic depiction of the prostate gland and the surrounding tissues [5]. The use of an 
endorectal (ER) receive coil helps MRI acquisition performance in terms of image quality 
and spatial resolution [6]. However, it deforms and displaces the prostate gland [7], 
produces some ER coil-based imaging artifacts [8], and detects more edges and details 
that challenge the adaptation of computer-assisted prostate contouring algorithms 
designed for non-ER MRI to this context. 
                                                 
† A version of this chapter has been submited: M. Shahedi, D. W. Cool, C. Romagnoli, G. S. Bauman, 
M. Bastian-Jordan, A. Fenster, and A. D. Ward, " Accuracy and acceptability validation of an automated 
method for prostate segmentation in magnetic resonance imaging," Medical Physics. 
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Manual segmentation of prostate MRI is a laborious and time-consuming task that 
is subject to inter-observer variability [9]. This motivates the need for fast and 
reproducible segmentation algorithms for T2w ER prostate MRI. There have been several 
algorithms published in the literature for segmentation of the prostate on T2w ER MRI. 
Martin et al. [10] presented a semi-automatic algorithm for segmentation of the prostate 
on MRI based on registration of an atlas to the test image. They evaluated their method 
on 17 MR images using manual segmentations performed by a single operator as the 
reference standard. To measure the accuracy of their method, they used a surface-based 
metric for different regions of interest (ROIs) including the whole prostate gland, base, 
midgland and apex regions. They also used region based metrics, but for the whole gland 
only. They reported higher atlas registration error, yielding to  higher segmentation error, 
for their methods on small prostates (less than 25 cm3) compared to the atlas registration 
error on the larger prostates. Vikal et al. [11] developed a two-dimensional (2D) slice-by-
slice segmentation algorithm based on shape modeling for three-dimensional (3D) 
segmentation of the prostate on T2w MRI. Their semi-automatic method was initialized 
by user selection of prostate centre point on one of the central slices of the prostate. In 
their method, segmentation starts from the selected central slice. The segmentation on 
each 2D slice is used as an initialization for segmenting its adjacent slice. They evaluated 
their method on three images using the mean absolute distance (MAD) and Dice 
similarity coefficient [12] (DSC), compared to a single reference standard developed by 
consensus of two expert observers. Toth and Madabhushi [13] developed a semi-
automatic segmentation algorithm based on a landmark-free active appearance model and 
level set shape representation method. To evaluate their method they applied the 
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algorithm to 108 T2w ER MRI and compared the results to manual segmentations 
performed by one observer using the MAD for the whole gland only and the DSC for 
whole-gland, apex, midgland and base. Although results were reported for a second 
observer on a subset of 17 images, inter-observer variability of their method was not 
reported. Liao et al. [14] presented a coarse-to-fine hierarchical automatic segmentation 
algorithm for prostate segmentation on T2w MRI. They used the MAD, DSC and 
Hausdorff distance error metrics for evaluation of their method on the whole gland using 
a manual reference segmentation performed by one observer on 66 T2w MR images. 
Cheng et al. [15] developed an automatic approach consisting of two main steps: first, a 
coarse segmentation based on an adaptive appearance model and then a segmentation 
refinement using a support vector machine. They used region-based metrics computed 
only within the whole gland to evaluate their method, using manual reference 
segmentations verified by one radiologist. In 2012, 11 teams were involved in a challenge 
for prostate MRI segmentation, called PROMISE12, held as part of the Medical Image 
Computing and Computer Assisted Intervention (MICCAI) conference. The challenge 
tested the performance of the segmentation algorithm presented by each team in two 
steps; online and live challenges. The image data set used by the challenge contained 
both ER and non-ER MR images and the results were evaluated against one set of manual 
segmentations provided by one expert and reviewed and edited, if necessary, by another 
expert using surface-, region- and volume-based metrics for the whole gland, apex and 
base regions [16]. 
In most previously published work, the segmentation result has been evaluated by 
comparison against a single manual reference segmentation. However, there is high inter-
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observer variability in contouring the prostate in MRI [9] and changing the manual 
reference segmentation used for segmentation evaluation likely has a substantial impact 
on the reported segmentation performance. Therefore, it is necessary to consider this 
variation when validating segmentation algorithms. Furthermore, in most published 
studies, the algorithm results have been evaluated using only one or two error metrics. 
Since each metric is sensitive to certain types of errors (e.g. the MAD is sensitive to 
large, spatially localized errors, whereas the DSC is sensitive to smaller, global errors), 
there is not a single globally-accepted metric for comprehensive evaluation of 
segmentation algorithms. Thus, using a set of metrics that are sensitive to different types 
of error such as surface disagreement, regional misalignment, and volume differences, 
yields a more comprehensive algorithm evaluation. Moreover, the accuracy and 
repeatability of the prostate segmentation varies for different parts of the gland in manual 
[9] and computer-based [10, 11, 13, 17] segmentations. Some groups reported 
segmentation error only for the whole prostate gland without reporting the error for the 
gland subregions such as the apex, mid-gland and base. Segmentation error metrics 
computed for the whole gland are challenging to interpret, since large errors in the apex 
and base regions can be offset by smaller errors in the mid-gland. When the 
segmentations are used to guide radiation or ablative interventions, this is especially 
important since the apex and base are near to sensitive structures such as the bladder, 
urethra, and penile bulb. 
We previously described a semi-automatic segmentation approach for ER prostate 
MRI based on local appearance and shape characteristics and evaluated its performance 
in comparison with manual segmentation in terms of accuracy and inter-operator 
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variability [17]. We applied our evaluation using different types of error metrics (i.e. 
surface-, region- and volume-based metrics) and assessed the performance of the 
algorithm over the whole prostate gland as well as within the apex, midgland and base 
subregions. Our semi-automatic segmentation method required that the user select four 
initial points to run the contouring algorithm. Thus, the algorithm’s segmentation results 
depended on the user’s judgment of the correct loci for these points. This included a 
requirement that the user indicate the apex-most and base-most slices of the prostate, 
which is a challenging task with substantial inter-observer variability. 
Although many segmentation algorithms have been proposed, an operator-
independent algorithm that has been comprehensively validated using multiple 
complementary error metrics against a multi-observer reference standard remains elusive. 
In this chapter, we build on our previous semi-automated segmentation algorithm to 
develop a fully automated approach that has no dependence on user input. We compare 
the fully automatic segmentation performance to the semi-automatic and manual 
approaches. We address the following four research questions in this chapter. (1) What is 
the accuracy of the automated segmentation algorithm when compared to a single-
observer manual reference standard?  (2) What is the difference in the time required to 
use our automated segmentation algorithm and our semi-automated segmentation 
algorithm?  (3) What is the difference in accuracy between our automated segmentation 
algorithm and our semi-automated segmentation algorithm?  (4) Is the measured 
misalignment between the computer-assisted segmentations and manual segmentations 
within the range of inter-expert variability in manual segmentation? 
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3.2 Materials and Methods 
3.2.1 Materials 
The data set contained 42 axial T2w fast spin echo ER MR images acquired from 
patients with biopsy-confirmed PCa. 23 of the images were acquired with TR = 4000–
13000 ms, TE 156–164 ms, NEX = 2, and for the other 19 images TR = 3500–7320 ms, 
TE = 102–116 ms, NEX = 1–2. Nine and 33 images were obtained with 1.5 and 3.0 Tesla 
field strengths, respectively. The voxel sizes varied from 0.27 × 0.27 × 2.2 mm to 0.44 × 
0.44 × 6 mm, covering the range typically seen in clinical prostate MRI. Four different 
MRI scanners were used for image acquisition: MAGNETOM Avanto, MAGNETOM 
Verio (Siemens Medical Solutions, Malvern, PA), Discovery MR 750 and Signa Excite 
(General Electric Healthcare, Waukesha, WI). The study was approved by the research 
ethics board of our institution, and written informed consent was obtained from all 
patients prior to enrolment. All 42 MR images were initially segmented manually by one 
observer (either a radiologist or a graduate student under advisement of a radiologist) 
followed by review and adjustment of the contours by an expert senior radiology resident 
with experience reading >100 prostate MRI scans. Two additional manual segmentations 
were performed on a subset of 10 images performed by two expert observers (one 
radiologist and one radiation oncologist). To select this subset of 10 images, we 
qualitatively assigned easy-, moderate- and difficult-to-segment labels to a set of images 
acquired at our institution and randomly select 10 images from all the three categories. 
The prostate volumes in the data set calculated based on the available manual 
segmentations ranged from 15 to 89 cm3 with mean ± standard deviation of 35 ± 14 cm3. 
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3.2.2 Automated segmentation 
Our automatic segmentation approach consists of two main parts: training and 
segmentation, described in sections 3.2.2.1 and 3.2.2.2, respectively. In this chapter, we 
focus on automation of the manual steps of our previously-published semi-automated 
method. Thus, we describe elements common to our automatic and semi-automatic 
approaches at a high level; full details on these elements are available in [17]. 
3.2.2.1 Training 
We use the approach to training described in reference [17] reporting on our semi-
automated segmentation method. The training method is described at a high-level here. 
During training, the algorithm learns the local appearance of the prostate border by 
extracting 36 locally defined circular mean intensity image patches, and generates a 2D 
statistical shape model for the prostate on each axial cross-section of the prostate. To 
extract the mean intensity image patches, we first spatially normalized all the prostates in 
the training set to define a spatial correspondence between axial slices of all the training 
images. For each slice in a set of corresponding axial slices, a set of 36 anatomically 
corresponding points was defined on the prostate border and for each point, a circular 
patch centered at that point was selected. By computing the average of the intensities of 
the corresponding pixels across all the patches obtained from the corresponding points, a 
set of 36 mean intensity patches were generated, each corresponding to one anatomical 
point on the prostate border. The 36 defined border points were also used for building a 
statistical point distribution model (PDM) of prostate shape on each selected axial cross-
section. 
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3.2.2.2 Segmentation 
To segment the prostate in a new MR image, the algorithm first coarsely localizes 
the region containing the prostate by automatically positioning a template shaped 
similarly to a prototypical prostate on the mid-sagittal plane (blue polygon in Figure 3.1). 
The algorithm then searches within a region defined according to this template to define 
the 3D prostate boundary. This high-level process resolves to a four-step procedure: (1) 
anterior rectal wall boundary determination, (2) inferior bladder boundary determination, 
(3) coarse prostate localization by template fitting, and (4) 3D prostate boundary 
localization. Each of these four steps is described in detail below. 
The first step was to fit a line to the anterior rectal wall boundary on the mid-
sagittal slice of the MRI. Candidate points lying on the anterior rectal wall boundary were 
selected by finding loci of minimum first derivative along line intensity profiles oriented 
parallel to the axial planes and running from anterior to posterior on the mid-sagittal 
plane. This approach was chosen due to the observation that the intensity generally 
transitions sharply from bright to dark at the rectal wall boundary. To reduce the search 
space, we restricted our search to a domain covering 50% of the width of the mid-sagittal 
plane in the anteroposterior direction, offset 20% from the posterior-most extent of the 
mid-sagittal plane. Within this domain, 10 equally-spaced lines (every second line) 
nearest to the mid-axial plane were searched. For robustness to outlier candidate points, 
we computed a least-trimmed squares fit [18] line to the candidate points, with the 
optimizer tuned to treat 40% of the candidate points as outliers. We took the resulting 
best-fit line to represent the anterior rectal boundary (posterior-most yellow dashed line 
in Figure 3.1). 
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The second step was to fit a curve to the inferior bladder boundary on the mid-
sagittal slice of the MRI. Candidate points lying on the inferior bladder boundary were 
selected by finding loci of minimum first derivative along line intensity profiles oriented 
parallel to the anterior rectal boundary determined in the previous step and running from 
superior to inferior on the mid-sagittal plane. This approach was chosen due to the 
observation that the intensity generally transitions sharply from bright to dark at the 
inferior bladder boundary. To reduce the search space we restricted our search to line 
segments lying within the superior half of the image, starting 5 mm anterior to the rectal 
wall with 2 mm spacing between them. We eliminated implausible candidate points in 
two stages. In the first stage, points forming a locally concave shape near the posterior 
side, inconsistent with anatomy of the inferior aspect of the bladder, were eliminated. In 
the second stage, we computed a least-trimmed squares fit [18] polynomial curve 
(second-order curve in the case of a point configuration yielding a convex shape; first-
order curve otherwise) to  the remaining candidate points, with the optimizer tuned to 
treat 20% of the candidate points as outliers. We took the resulting curve to represent the 
inferior bladder boundary (superior-most yellow dashed curve in Figure 3.1). 
The third step was to fit the prostate template (described by the dimensions shown 
in Figure 3.1) to the image using the anatomic boundaries found in the first and second 
steps. This was done by defining the dimensions of the template to match the 
anteroposterior (AP) and inferior-superior (IS) dimensions of the prostate on the test 
image; this information is readily available in every clinical case from the prostate 
ultrasound examination conducted prior to MRI. The template was then positioned 
parallel to and 3 mm anterior to the rectal wall line (along a line perpendicular to the 
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rectal wall line), inferior to the bladder boundary curve with a single point of contact 
between the bladder boundary and the template (Figure 3.1). 
The fourth and final step was to define the 3D surface of the prostate detected and 
localized by the template. After fitting the template to the image, we extract a set of three 
points (three blue crosses in Figure 3.1) from the template: the prostate centre points on 
(1) the apex-most slice, (2) the base-most slice, and (3) the midgland slice equidistant to 
the apex- and base-most slices. We then interpolate these three centre points using 
piecewise cubic interpolation to estimate the centre points for all of the axial slices 
between the apex and base. We then use the approach to prostate boundary localization 
described in reference [17] reporting on our semi-automated segmentation method. The 
approach is described at a high level here. For each slice, we oriented a set of 36 equally 
spaced rays emanating from the centre point, one corresponding to each of the learned 
mean intensity patches. For each ray we translated the corresponding mean intensity 
patch to find the point whose circular image patch has the highest normalized cross-
correlation with the corresponding mean intensity path. Shape regularization was 
performed within each slice using the corresponding PDM, followed by 3D shape 
regularization. Full details are available in [17]. 
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Figure 3.1: Automatic coarse localization of the prostate. The dashed line shows the 
estimated tangent line to the rectal wall. The dashed curve shows the estimated bladder 
border. The solid line polygon is the template used to select the centre points for apex, 
midgland and base. The prostate border based on manual segmentation has been overlaid 
in dotted line as a reference. AP and IS are ,respectively, anterioposterior and inferior-
superior dimensions of the prostate measured during routine clinical ultrasound imaging. 
The three indicated points on the template define the three estimated centre points for the 
prostate. 
3.2.3 Validation 
To evaluate the accuracy of the segmentation algorithm, we used complementary 
boundary-based, regional overlap-based, and volume-based metrics. This allows the user 
of the method to understand its applicability to a specific intended workflow. For 
instance, the use of this algorithm for planning whole-prostate radiation would increase 
the importance of low error in a boundary-based metric, whereas the use of the algorithm 
in a retrospective study correlating prostate size with clinical outcome would focus on 
accuracy of a volume-based metric. We used the MAD as the boundary-based error 
metric; the DSC, recall rate and precision rate as regional overlap-based error metrics; 
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and the volume difference (ΔV) metric to evaluate the automatic segmentation against 
manual segmentation. We measured the metrics in 3D for the whole prostate gland and 
also for the inferior-most third of the gland (corresponding to the apex region), the 
middle third of the gland (corresponding to the midgland region) and the superior-most 
third of the gland (corresponding to the base region). 
MAD measures the misalignment of two surfaces in 3D in terms of absolute 
Euclidean distance. To calculate the MAD in a unilateral fashion, the surface of each 
shape is defined as a set of points, with one of the two shapes designated as the reference. 
The MAD is the average of the absolute Euclidean distances between each point on the 
non-reference set to the closest point on the reference set. Specifically, 
 
𝑀𝐴𝐷(𝑋, 𝑌) =
1
𝑁
∑ min
𝑞∈𝑌
𝐷(𝑝, 𝑞)
𝑝∈𝑋
 , (3.1) 
where X and Y are the point sets (Y is the reference set), N is the number of points in X, p 
is a point in X, q is a point in Y, and D(p,q) is the Euclidean distance between p and q. 
The MAD is an oriented metric and is therefore not invariant to the choice of 
reference shape. This can be addressed by calculating the bilateral MAD, which is the 
average of the two unilateral MAD values calculated taking each shape as the 
reference.To calculate the DSC [12], recall rate and precision rate [17], we measured the 
volume overlap between the two 3D shapes. Figure 3.2 and equations (3.2), (3.3) and 
(3.4) define DSC, recall and precision, respectively. 
 
𝐷𝑆𝐶(𝑋, 𝑌) =
2(𝑋 ∩ 𝑌)
𝑋 + 𝑌
=
2𝑇𝑃
𝐹𝑃 + 2𝑇𝑃 + 𝐹𝑁
 (3.2) 
 
𝑅𝑒𝑐𝑎𝑙𝑙(𝑋, 𝑌) =
𝑇𝑃
𝑇𝑃 + 𝐹𝑁
 
(3.3) 
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𝑃𝑟𝑒𝑐𝑖𝑠𝑖𝑜𝑛(𝑋, 𝑌) =
𝑇𝑃
𝑇𝑃 + 𝐹𝑃
 
(3.4) 
We subtract the volume of the reference shape from the volume of the test shape 
to calculate the signed volume difference (ΔV) metric 
 ∆𝑉(𝑋, 𝑌) = 𝑉𝑎𝑙𝑔𝑜𝑟𝑖𝑡ℎ𝑚 − 𝑉𝑟𝑒𝑓𝑒𝑟𝑒𝑛𝑐𝑒  , (3.5) 
where Valgorithm and Vreference are the prostate volumes given by the segmentation algorithm 
and manual reference segmentation, respectively. Negative and positive values of ΔV 
indicate under-segmentation and over-segmentation, respectively. 
  
Figure 3.2: Elements used to calculated the DSC, recall, and precision validation metrics. 
X and Y are the two shapes, with Y taken as the reference shape. FP: false positive, TP: 
true positive, FN: false negative. 
3.3 Experiments 
For all of the experiments in this chapter, all algorithm parameters were tuned 
identically to those used in reference [17] to allow for direct comparison of the results. 
3.3.1 Comparison of automatic and semi-automatic segmentation: accuracy 
and time 
We ran the automatic segmentation algorithm on our data set of 42 3D images and 
compared the results to a single manual reference segmentation using leave-one-patient-
Y(reference)X
(TP)
FP FN
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out cross validation. We compared each segmentation result against the reference using 
our five error metrics on the four ROIs; the whole gland, apex, midgland and base 
regions. We applied one-tailed heteroscedastic t-tests [19] to compare the performance of 
the automatic segmentation to the semi-automatic segmentation. We measured the 
average execution time for the automatic segmentation approach across the 42 images 
and compared it to the average of semi-automatic execution time across the same data set 
and identical running conditions, using a one-tailed t-test. 
3.3.2 Comparison of automatic and semi-automatic segmentation versus 
inter-operator variability in manual segmentation 
We ran the automatic algorithm on the subset of 10 images for which we had 
three manual reference segmentations. For comparison, we also applied our semi-
automatic algorithm [17] to the same data set using nine different operators (four 
radiation oncologists, one radiologist, one senior radiology resident, one imaging 
scientist, and two graduate students, all with clinical and/or research experience with 
prostate imaging). We used the remaining 32 images for training both algorithms. We 
compared each segmentation result against the manual reference segmentations using our 
five error metrics on the four ROIs; the whole gland, apex, midgland and base regions. 
For the automatic segmentation method, we calculated the mean and standard 
deviation of each metric for each ROI across all 10 images and three references, defined 
as 
 
ℳ̅𝑀𝑒𝑡𝑟𝑖𝑐
𝑎 =
1
𝑀 × 𝐾
∑ ∑ 𝑀𝑒𝑡𝑟𝑖𝑐(𝐿𝑖
𝑎, 𝐿𝑖
𝑘)
𝐾
𝑗=1
𝑀
𝑖=1
 and (3.6) 
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𝜎𝑀𝑒𝑡𝑟𝑖𝑐
𝑎 = √
1
(𝑀 × 𝐾 − 1)
∑ ∑[𝑀𝑒𝑡𝑟𝑖𝑐(𝐿𝑖
𝑎 , 𝐿𝑖
𝑘) − ℳ̅1
𝑎]
2
𝐾
𝑗=1
𝑀
𝑖=1
, 
(3.7) 
where 𝑀𝑒𝑡𝑟𝑖𝑐 is a function computing any one of the five metrics (e.g. MAD); ℳ̅𝑀𝑒𝑡𝑟𝑖𝑐
𝑎  
is the mean value of the metric for automatic segmentation across all the images and all 
the references; 𝜎ℳ1
𝑎  is the standard deviation of the metric; M=10 and K=3 are the 
number of images and references, respectively; 𝐿𝑖
𝑘is the manual segmentation by the kth 
operator on the ith image; and 𝐿𝑖
𝑎is the automatic segmentation on the ith image. For the 
semi-automatic segmentation, we calculated the mean and standard deviation of each 
metric for each ROI across all 10 images, three references and nine operators, defined as 
 
ℳ̅𝑀𝑒𝑡𝑟𝑖𝑐
𝑠 =
1
𝑀 × 𝑁 × 𝐾
∑ ∑ ∑ 𝑀𝑒𝑡𝑟𝑖𝑐(𝐿𝑖
𝑠𝑗 , 𝐿𝑖
𝑘)
𝐾
𝑘=1
𝑁
𝑗=1
𝑀
𝑖=1
 and (3.8) 
 
𝜎𝑀𝑒𝑡𝑟𝑖𝑐
𝑠 = √
1
(𝑀 × 𝑁 × 𝐾 − 1)
∑ ∑ ∑[𝑀𝑒𝑡𝑟𝑖𝑐(𝐿𝑖
𝑠𝑗 , 𝐿𝑖
𝑘) − ℳ̅1
𝑠]
2
𝐾
𝑘=1
𝑁
𝑗=1
𝑀
𝑖=1
, 
(3.9) 
where ℳ̅𝑀𝑒𝑡𝑟𝑖𝑐
𝑠  is the mean value of the metric across all the semi-automatic labels, all 
the images and all the references; 𝜎ℳ1
𝑠  is the standard deviation of the metric; N=9 is the 
number of operators; and 𝐿𝑖
𝑠𝑗
is the semi-automatic segmentation by the jth operator on the 
ith image. 
We used Simultaneous Truth and Performance Level Estimation (STAPLE) [20] 
to generate one reference segmentation from each triplet of manual segmentations 
performed on each image. We then computed ℳ̅𝑀𝑒𝑡𝑟𝑖𝑐
𝑎  and  ℳ̅𝑀𝑒𝑡𝑟𝑖𝑐
𝑠  using the STAPLE 
reference exactly as in Equations (3.6)–(3.9), with 𝐾 = 1 (reflecting the use of a single 
STAPLE reference rather than 3 manual references). 
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We compared the semi-automatic and automatic approaches separately for both 
explained scenarios (three manual references and single STAPLE reference) using one-
tailed heteroscedastic t-tests. We defined the range of mean values of each metric 
(𝐵𝑀𝑒𝑡𝑟𝑖𝑐
𝐿  𝑡𝑜 𝐵𝑀𝑒𝑡𝑟𝑖𝑐
𝐻 ) when we compared three manual segmentations pairwise  reported in 
[17] as follows: 
 𝐵𝑀𝑒𝑡𝑟𝑖𝑐
𝐿 = min
𝑚,𝑛
ℳ̅𝑀𝑒𝑡𝑟𝑖𝑐
𝑚,𝑛  and (3.10) 
 𝐵𝑀𝑒𝑡𝑟𝑖𝑐
𝐻 = max
𝑚,𝑛
ℳ̅𝑀𝑒𝑡𝑟𝑖𝑐
𝑚,𝑛 , (3.11) 
Where 
 
ℳ̅𝑀𝑒𝑡𝑟𝑖𝑐
𝑚,𝑛 =
1
𝑀
∑ 𝑀𝑒𝑡𝑟𝑖𝑐(𝐿𝑖
𝑚, 𝐿𝑖
𝑛) and
𝑀
𝑖=1
 (3.12) 
𝐿𝑖
𝑚 and 𝐿𝑖
𝑛 are the manual segmentations for ith image by observers m and n, respectively. 
Wecompared the mean metric values for semi-automatic and automatic segmentation 
(ℳ̅𝑀𝑒𝑡𝑟𝑖𝑐
𝑎  and  ℳ̅𝑀𝑒𝑡𝑟𝑖𝑐
𝑠 ) to this range. If the average of a metric at one ROI is within this 
manual segmentation variability range or even the observed average error is below the 
range, we took it into account as an improvement in accuracy and variability of the 
algorithms compared to manual segmentation. 
3.4 Results 
3.4.1 Comparison of automatic and semi-automatic segmentation: accuracy 
and time 
The results in this section address research questions (1), (2), and (3) as described 
in the introduction. Table 3.1 shows our automatic segmentation accuracy on 42 T2w MR 
images against one manual reference segmentation. The results of the t-tests (with 
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α=0.05) showed that using the automatic algorithm significantly increased the error in 
terms of MAD and DSC in all the ROIs. Recall rates significantly decreased for the 
whole gland, apex and midgland and significantly increased for the base when we used 
the automatic segmentation algorithm. The precision rate also showed more error within 
the whole gland, midgland and base. No significant changes were detected within the 
apex in terms of the precision rate. We did not detect a significant increase in error for the 
whole gland and midgland in terms of ΔV. The absolute value of ΔV was significantly 
increased within the apex and significantly decreased within the base. 
The mean ± standard deviation execution time using an unoptimized MATLAB 
platform on a single CPU core for coarse prostate localization was 3.2 ± 2.1 sec. and for 
3D segmentation was 54 ± 13 sec. 
Table 3.1: Accuracy of automatic segmentation: mean ± standard deviation of MAD, 
DSC, recall, precision, and ΔV. § and * show statistically significant accuracy gain and 
loss, respectively, when compared to the results of semi-automatic segmentation in [17] 
(p < 0.05). 
Region of 
Interest 
MAD 
(mm) 
DSC 
(%) 
Recall 
(%) 
Precision 
(%) 
ΔV 
(cm3) 
Whole Gland 3.2 ± 1.2* 71 ±  11* 69 ±  15* 76 ±  12* -3.6 ± 10.4 
Apex 2.8 ± 1.3* 66 ±  15* 62 ±  23* 81 ±  17 -3.3 ± 5.1* 
Midgland 2.8 ± 1.1* 82 ±   9* 82 ±  15* 84 ±  10* -0.5 ± 3.6 
Base 3.8 ± 1.7* 64 ±  15* 71 ±  21§ 69 ±  22* 0.2 ± 7.5§ 
3.4.2 Comparison of automatic and semi-automatic segmentation versus 
inter-operator variability in manual segmentation 
The results in this section address research question (4) as described in the 
introduction. In this experiment, the key result was that the accuracy of semi-automatic 
and automatic segmentation algorithms approaches the observed inter-operator variability 
range in manual segmentation. Figure 3.3 shows the mean ± standard deviation of the 
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five metric values for each ROI for semi-automatic and automatic segmentation 
algorithms, compared with the range of the mean of each metric within each ROI in pair-
wise comparison of the three manual reference segmentations. Figure 3.4 shows the mean 
± standard deviation values for the five metrics for each region of interest for semi-
automatic and automatic segmentation algorithms in comparison with STAPLE reference 
segmentations. We overlaid the results of each metric lower and upper bounds at each 
ROI in comparison of the three manual reference segmentations against STAPLE 
reference using dashed lines. Note that in both Figure 3.3 and Figure 3.4 if the metric 
value for each algorithm located within the range or at the lower error side it means that 
the algorithm accuracy reached the observed inter-expert observer variation in manual 
segmentation, and if the metric value located beyond the higher error bound that means 
there could be still room for improvement of the algorithm accuracy. As these figures 
show depends on the metric and ROI each of the algorithms might have outperformed the 
other. In terms of some of the metrics at some of the ROIs no statistically significant 
difference were detected between semi-automatic and automatic algorithms. 
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Figure 3.3: Accuracy of the computer-based segmentations vs. inter-operator variability 
of manual segmentation. The average accuracy of one set of 10 automatic and nine sets of 
10 semi-automatic segmentations in comparison with three manual reference 
segmentations in terms of (a) MAD, (b) DSC, (c) recall, (d) precision and (e) ΔV. The 
dashed line segments show the observed range of each metric at each ROI in pair-wise 
comparison between three manual segmentations. For ΔV, the ranges are based on the 
absolute value of ΔV due to lack of reference in comparison of two manual 
segmentations. The significant differences detected between semi-automatic and 
automatic segmentation at different ROIs have been indicated on the graphs (p-value < 
0.05). 
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Figure 3.4: Accuracy of the computer-based segmentations vs. inter-operator variability 
of manual segmentation. The average accuracy of one set of 10 automatic and nine sets of 
10 semi-automatic segmentations in comparison with STAPLE reference segmentation in 
terms of (a) MAD, (b) DSC, (c) recall, (d) precision and (e) ΔV. The dashed line 
segments show the observed range of each metric at each ROI in comparison between 
three manual segmentations and STAPLE reference. The significant differences detected 
between semi-automatic and automatic segmentation at different ROIs have been 
indicated on the graphs (p-value < 0.05). 
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3.5 Discussion 
In this work, we measured the segmentation accuracy gained or lost when using a 
fully-automatic version of a previously-published semi-automatic segmentation 
algorithm. Such comparisons are routinely performed in the literature, often using a small 
number of validation metrics and a single-observer reference standard. In this work, we 
extended our analysis beyond this traditional approach to include a comparison of the 
algorithm performance differences to inter-observer variability in segmentation error 
metrics resulting from different expert manual segmentations. Measuring performance 
differences between algorithms – those presented in this chapter or in other literature – in 
the context of expert manual segmentation variability is important to understanding the 
practical importance of algorithm performance differences. 
3.5.1 Comparison of automatic and semi-automatic segmentation: accuracy 
and time 
For comparison to our previous results and other published work, we conducted 
an experiment using a single manual reference segmentation to measure the accuracy of 
our automatic algorithm. In terms of most of the metrics, there was a statistically 
significant difference between automatic and semi-automatic segmentation errors. On 
average, by switching from semi-automatic segmentation to automatic segmentation, 
MAD increases by 1.2 mm, DSC decreases by 11%, recall decreases by 8%, precision 
decreases by 12%, and the error in prostate volume decreases by 1 cm3 for the whole 
gland. According to the results based on our multi-reference and/or multi-operator 
experiments (Figure 3.3), the absolute value of the average ΔV based on automatic 
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segmentation on whole gland significantly decreased from approximately 7 cm3 to less 
than 1 cm3. This illustrates the complementary nature of the validation metrics and the 
varying utility of different segmentations for different purposes. Whereas the automatic 
segmentations may be less preferable to the semi-automatic segmentations for therapy 
planning, the automatic segmentations may be preferable for correlative studies involving 
prostate volume and clinical outcomes. 
The nature of the data set used in PROMISE12 challenge is different from our 
data set in terms of the consistent use of the an ER coil for MRI acquisition; our data set 
contained only images acquired using the ER coil, whereas the PROMISE12 data set 
contained a some with and some without the ER coil. However if we compare our results 
in Table 3.1 to the published results in [16] where applicable, our results are within the 
range of the metric values reported for the PROMISE12 challenge. 
In the semi-automatic approach, the operator provided coarse prostate 
localization, whereas in the automatic approach, this was done entirely by the algorithm. 
To compare the time required for this step in both contexts, the mean measured operator 
interaction time for semi-automatic segmentation was approximately 30 seconds [17], 
whereas the mean measured time required for automatic coarse prostate localization was 
measured in this study to be approximately 3 seconds using unoptimized MATLAB code 
on a single CPU core. 
 
114 
 
3.5.2 Comparison of automatic and semi-automatic segmentation versus 
inter-operator variability in manual segmentation 
The measured accuracy differences between the automatic and semi-automatic 
approaches are nearly always smaller than the measured differences between manual 
observer contours (differences between gray and black bars versus differences between 
dashed lines on Figure 3.3), and also smaller than the measured differences between 
manual observer contours and a STAPLE consensus contour (Figure 3.4). This suggests 
that the performance differences measured between these two algorithms may be less 
than the differences we would expect when comparing different observers’ manual 
contours. 
We observe that the top of the dark gray bar corresponding to the MAD metric in 
Figure 3.3 for the whole gland lies within the range of variability between expert 
observers’ manual contours. This indicates that on average, the semi-automatic 
segmentation algorithm’s whole-gland segmentation accuracy, as measured by MAD, is 
within the range of human expert variability in manual contouring. This means that 
further investment of engineering efforts to improve this metric for this algorithm may 
not be beneficial to the ultimate clinical workflow, since the algorithm’s error is already 
smaller than the difference that might be observed between expert observers’ manual 
contours. The fact that the top of the light gray bar in the same part of the figure lies 
higher than the range given by the dashed lines indicates that this is not the case for the 
fully automatic algorithm; further accuracy improvement in terms of MAD on the whole 
gland may be warranted, with the caveat that such improvement must be measured using 
a multi-observer reference standard. Inter-observer variability in manual segmentation 
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would likely mask small improvements in the MAD; this is evidenced by the size of the 
gap between the dashed lines (1.8 mm), compared to the 0.6 mm improvement in the 
MAD that would be necessary to yield equal performance to the semi-automatic 
algorithm. We observe in Figure 3.3 that for the MAD, DSC, precision, and ΔV metrics, 
algorithm performance is near or within the range of human expert variability; this is the 
case more often for the semi-automatic algorithm. The performance of the algorithms in 
terms of the recall metric suggest that overall, both algorithms tend to undersegment the 
prostate to an extent where there is practically important room for improvement. This is 
especially true for the base region of the prostate. Interestingly, in terms of the recall 
metric, the automatic algorithm had statistically significantly better performance than the 
semi-automatic algorithm for every anatomic region except for the apex, with 
substantially better performance in the base region. This is concordant with our 
observations [17] of large inter-observer variability in determining the slice location of 
the base during initialization of the semi-automated algorithm; determining where the 
prostate base ends and the bladder neck begins is a challenging task even for expert 
physicians. The observations made in Figure 3.4, where the range of observer variability 
relative to a STAPLE reference are shown, are generally concordant with observations 
made on Figure 3.3. 
Taken as a whole, these observations highlight the value of measuring inter-
observer variability in manual segmentation, using complementary segmentation error 
metrics, and measuring segmentation error in different anatomic regions known to pose 
varying levels of challenge to expert operators and automated algorithms. Analysis of 
these quantities as performed above allows us to determine the best ways to focus further 
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engineering efforts to improve automated segmentation algorithms. A clinical end user 
can identify the segmentation error metrics of greatest relevance to the user’s intended 
application of the algorithm and use the plots in Figure 3.3 to determine whether a 
particular algorithm’s accuracy in terms of those metrics is within the range of human 
expert variability in manual segmentation. If so, the algorithm is ready to be moved 
forward for full retrospective validation and then prospective testing within the intended 
clinical workflow. If the analysis shows there is room for improvement to bring the 
algorithm within the range of human performance for one or more anatomic regions, 
further engineering efforts can be specifically focused accordingly. We anticipate that 
this form of segmentation performance analysis will enrich future studies of automated 
segmentation algorithms intended for use on the prostate and other anatomic structures, 
enabling a means for determining the point at which an algorithm is ready to move 
forward from bench testing toward clinical translation. 
3.5.3 Limitations 
The results of our work should be considered in the context of its strengths and 
limitations. First, although the automatic segmentation algorithm does not require any 
user interaction with the images, it does depend on the IS and AP dimensions of the 
prostate as determined on the routine clinical ultrasound imaging that is performed as part 
of guided biopsy before any MRI study would be conducted. In this study, the IS and AP 
dimensions taken from manual MRI prostate segmentation were used as surrogates for 
the measurements that would be taken during clinical ultrasound, and the performance 
sensitivity of the automatic segmentation method to these measurements was not 
determined. Second, our 3D segmentation algorithm requires the AP symmetry axis of 
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the prostate for orientation information. Since during MRI acquisition the scanner 
operator aligns the midsagittal plane of the scan to the midsagittal plane of the prostate 
using localizer scans, we assumed that the AP symmetry axis of the prostate gland is 
oriented parallel to AP axis of the image and assumed that all three prostate centre points 
(at the apex, mid-gland and base) are located on the mid-sagittal plane of the image. 
These assumptions are supported by our observations that segmentation algorithm is 
robust to perturbations of the AP symmetry axis and centre point selection [17] but 
nevertheless we felt it important to acknowledge these assumptions. Third, the small size 
of our data set (42 single-reference images and 10 multi-reference images) limits the 
strength of the conclusions of our work. Finally, we used MR image intensity as the only 
image feature for prostate border detection and we did not use other image-derived 
features such as image texture. Using other features might add complexity to the method 
and may make the algorithm slower, however it could improve the accuracy of the 
segmentation. Moreover, to have a more reliable assessment on the segmentation 
algorithm, we still need to study the effects of post-segmentation manual editing on 
prostate segmentation time, accuracy and reproducibility; this is the subject of our 
ongoing work. 
3.5.4 Conclusions 
In this work, we described an automatic 3D prostate segmentation method 
intended for use on T2w prostate MRI acquired using an endorectal receive coil. We 
compared it to a semi-automated algorithm using complementary error metrics separately 
in the apex, mid-gland, and base. We evaluated the algorithms’ accuracies in the context 
of expert variability in manual segmentation. We addressed four key research questions 
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described in the introduction section of this chapter, the answers to which are enumerated 
accordingly here. (1) When compared to a single-observer reference standard, the 
automatic algorithm has an average MAD of 2.8 mm, DSC of 82%, recall of 82%, 
precision of 84%, and volume difference of 0.5 cm3 in the mid-gland. Concordant with 
results from other published algorithms, accuracy was highest in the mid-gland and lower 
in the apex and base regions of the prostate. (2) The use of the automated algorithm 
eliminated the need for 30 seconds of user interaction to perform coarse localization of 
each prostate, replacing this step with a fully automatic approach requiring no user 
interaction and needing 3 seconds of computation time. (3) The automatic algorithm’s 
accuracy did not differ from the semi-automatic algorithm’s accuracy by more than 1 mm 
in terms of MAD; 5% in terms of DSC, precision, and recall; and 8 cm3 in terms of 
volume. The differences between the automatic and semi-automatic segmentation error 
metrics were consistently smaller than the differences observed between manual contours 
performed by experts. (4) The segmentation error metric values were near to or within the 
range of expert manual segmentation variability for all but the recall metric, especially in 
the prostatic base. This suggests that for our algorithms, engineering efforts should be 
focused on further improvement of the segmentation of the base, which is challenging 
even for human experts. The analysis approach taken in this chapter provides a means for 
determining the readiness of a segmentation algorithm for translation toward clinical trial 
for a specific purpose, and for focusing further engineering efforts on the most practically 
relevant performance issues, supporting eventual achievement of clinical translation. 
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Chapter 4. 
  
Impact of physician editing on repeatability and time 
for manual and computer-assisted prostate 
segmentation on magnetic resonance imaging † 
 
4.1 Introduction 
In 2014, prostate cancer (PCa) was one of the most commonly diagnosed types of 
cancer and the second leading cause of death from cancer among men in North America 
[1, 2]. Due to its high soft tissue contrast, magnetic resonance (MR) imaging (MRI) has 
demonstrated potential for detection, localization and staging of PCa [3-6] and therefore 
in several centers MRI is being used for PCa diagnosis, treatment planning and therapy 
guidance [3, 6-8]. Using an endorectal receiver (ER) coil during MRI acquisition yields 
images with higher resolution and improved signal-to-noise ratio, with reported positive 
impact on PCa diagnosis [7, 9, 10]. 
Delineation of the prostate capsule on MRI is required for several clinical 
procedures in which MR images are employed. T2-weighted (T2w) prostate MRI plays 
an important role in anatomy description [11, 12], PCa detection and localization [13], 
and therefore, prostate contouring is usually performed on T2w MRI. However, three-
                                                 
† A version of this chapter is in preparation for submission: M. Shahedi, D. W. Cool, C. Romagnoli, 
G. S. Bauman, M. Bastian-Jordan, G. Rodrigues, B. Ahmad, M. Lock, A. Fenster, and A. D. Ward, " 
Impact of physician editing on repeatability and time for manual and computer-assisted prostate 
segmentation on magnetic resonance imaging," (in preparation). 
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dimensional (3D) manual prostate contour delineation is laborious and time-consuming, 
and subject to substantial inter-operator variability [14]. 
Several algorithms have been presented in the literature for 3D segmentation of 
the prostate on T2w MRI, as described in a recent survey [15]. However, a minority of 
these methods have been validated for use on T2w MRI acquired using an ER coil 
(henceforth referred to as ER MRI). Although ER MRI can improve PCa detection, its 
improved contrast results in the presence of additional high-frequency details in the 
images. This makes automatic segmentation more challenging, especially for algorithms 
designed for use on non-ER MRI where the intraprostatic signal is more homogeneous. 
Furthermore, the ER coil deforms and displaces the prostate gland and produces MRI 
artifacts [16] that further challenge automatic segmentation. We have previously reported 
on semi-automatic [17] and automatic (Chapter 3) segmentation algorithms developed in 
our laboratory. Full details are available in the original publications; we describe details 
relevant to this study here. These methods are based on prostate shape and appearance 
models learned from a training set. Segmentation is performed in two steps: coarse 
localization of the prostate, followed by 3D segmentation boundary detection and 
refinement. In the semi-automated approach, coarse localization is performed by the 
operator with four mouse clicks requiring approximately 30 seconds of user interaction 
time. In the automated approach, coarse localization is performed automatically within 3 
seconds of computation time, with no requirement for user interaction. 
A range of segmentation accuracy values has been reported in the literature for 
automated and semi-automated algorithms (Table 4.1). Typically, reported error metrics 
include the mean absolute distance (MAD) between the boundaries of the automatic and 
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manual segmentations, and/or the Dice similarity coefficient (DSC). Reported MAD 
values range from 1.5–3.4 mm [17-20], and reported DSC values range from 82%–91% 
[17-21]. Reasons for the range of different error values reported include algorithm design, 
the use of single-operator manual reference segmentations for validation in most studies, 
and the use of different imaging data sets. These differences notwithstanding, the errors 
yielded by state-of-the-art segmentation methods are asymptotically approaching the 
differences observed between human expert operators [14]. It is thus timely to shift the 
focus of research in this area to studies aimed at enabling clinical translation of these 
techniques so that they can be of benefit to those suffering from cancer. 
For reasons of diagnostic accuracy and patient safety, the integration of any 
computer-assisted segmentation algorithm, fully automatic or otherwise, into clinical use 
will require that an expert reviews and edits each segmentation as necessary before 
proceeding. This will always be necessary since regardless of the reported accuracy of a 
given segmentation algorithm, unusual cases will occur in the clinic that result in poor-
quality computer-assisted segmentations, with potentially disastrous consequences to the 
patient if such segmentations were used to guide treatment. Therefore, the clinical utility 
of a method will depend not only on its accuracy metric values, such as the MAD and 
DSC, determined on a testing data set, but also on the amount of editing deemed 
necessary by expert physicians in order to render the segmentation suitable for clinical 
use. This editing can be measured spatially using standard metrics such as MAD and 
DSC, to compare the segmentation as output by the algorithm to the segmentation after 
editing, and these metrics can be computed on anatomically distinct regions to learn 
about the portions of the prostate requiring the most editing. Potentially of even greater 
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importance, the amount of required editing time can be measured. For a segmentation 
algorithm to have clinical utility, it must allow the expert physician to obtain a 
segmentation deemed clinically acceptable by him/her in less time than would be 
required to perform a manual segmentation. This statement holds true regardless of the 
reported segmentation accuracy metrics (e.g. MAD, DSC) for an algorithm in the 
literature. To the best of our knowledge, questions of editing magnitude and time have 
not been extensively studied for ER MRI prostate segmentation algorithms reported in 
the literature. 
In this chapter, we conducted a user study to answer four research questions. (1) 
How much spatial segmentation editing do expert operators perform to obtain clinically 
useful segmentations?  (2) What is the inter-operator variability in segmentation?  (3) 
How much segmentation editing time do expert operators require to obtain clinically 
useful segmentations?  (4) Can the necessary time requirement for segmentation editing 
be predicted from spatial segmentation error metrics?  Questions (1), (2), and (3) were 
answered and compared under three conditions, where the segmentations provided to the 
operators for editing came from (a) our automatic segmentation algorithm, (b) our semi-
automatic segmentation algorithm, and (c) manual segmentation performed by another 
expert operator. As the scope of question (4) is limited to evaluation of computer-assisted 
segmentation algorithms, it was answered under conditions (a) and (b) only. 
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Table 4.1: Reported segmentation errors for prostate segmentation algorithms intended 
for use on T2w ER MRI. 
Algorithm Technique Data set size Accuracy Segmentation time 
Our semi-
automatic 
algorithm [17] 
(described in 
Chapter 2) 
Local appearance and 
shape model (semi-
automatic) 
42 
(test and 
training) 
Whole gland: 
MAD: 2.0 ± 0.5 mm 
DSC: 82% ± 4%  
Recall: 77% ± 9% 
Precision: 88% ± 6% 
ΔV: -4.6 ± 7.2 cm3 
Operator interaction: 
28 ± 14 sec. (across 
10 images and 9 
operators) 
Execution: 85 ± 20 
sec. (across 42 
images, one 
operator) 
Our automatic 
algorithm 
(described in 
Chapter 3) 
Local appearance and 
shape model (automatic) 
42 
(test and 
training) 
Whole gland: 
MAD: 3.2 ± 1.2 mm 
DSC: 71% ± 11%  
Recall: 69% ± 15% 
Precision: 76% ± 12% 
ΔV: -3.6 ± 10.4 cm3 
Execution: 54 ± 13 
sec. (across 42 
images) 
Cheng et al. [21] Atlas-based (automatic) 
100 
(training) and 
40 (test) 
Whole gland: 
TP: 91.2% 
DSC: 87.6% 
ΔV: 8.4% 
NA 
Liao et al. [18] 
Multi-atlas-based 
(automatic) 
66 (test) 
9 (atlas) 
Whole gland: 
MAD: 1.8 ± 0.9 mm 
DSC: 88% ± 3%  
Execution: 2.9 min. 
Toth and 
Madabhushi [19] 
Active appearance model 
(semi-automatic) 
108 
Whole gland: 
MAD: 1.5 ± 0.8 mm 
DSC: 88% ± 5%  
Execution: 150 sec. 
Vikal et al. [22] 
Shape model (semi-
automatic) 
3 Has not reported for whole gland Execution: 23 sec. 
Martin et al. [20] 
Atlas-based (semi-
automatic) 
1 (reference) 
17 (test) 
Whole gland: 
MAD: 3.4 ± 2.0 mm 
Recall: 89% ± 6% 
Precision: 78% ± 12% 
NA 
MAD: mean absolute distance, DSC: Dice similarity coefficient, ΔV: Volume difference, TP: true positive 
4.2 Materials and Methods 
4.2.1 Materials 
Our sample consisted of 10 axial T2w fast spin echo ER MRI acquired at 3.0 
Tesla field strength, all from patients with biopsy-confirmed PCa. Images were acquired 
with TR = 4000–13000 ms, TE 156–164 ms, NEX = 2. The voxel sizes were 0.27 × 0.27 
× 2.2 mm as is typically seen in clinical prostate MRI. The images were acquired using a 
Discovery MR750 (General Electric Healthcare, Waukesha, WI). The study was 
approved by the research ethics board of our institution, and written informed consent 
was obtained from all patients prior to enrolment. All 10 MR images were segmented 
manually by three operators: one radiologist, one radiation oncologist and an expert 
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radiology resident with >3 years’ experience reading >100 prostate MRI studies in 
tandem with a board-certified radiologist as part of a trial conducted at our centre. Editing 
was conducted by four radiation oncologists with genitourinary specialization and the 
same expert radiology resident. The ITK-SNAP software tool [23] was used for manual 
segmentation. 
  
Figure 4.1: Study design showing the workflow for a particular operator #i. The operator 
edited three sets of segmentations: five automatic segmentations, five semi-automatic 
segmentations performed by the operator, and five semi-automatic segmentations 
performed by a different operator #j. Spatial and temporal segmentation metrics were 
collected to measure the editing task and compared across the three conditions. 
4.2.2 Study design 
Our study design is shown in Figure 4.1. Each operator #i edited a total of 15 
segmentations under three conditions: (a) five automatic segmentations, (b) five semi-
automatic segmentations performed based on the operator’s own inputs as the semi-
automatic segmentation algorithm operator, and (c) five manual segmentations performed 
by a different expert operator #j. Operator #j was the same individual throughout the 
T2w MRI
(n = 10)
T2w MRI
(n = 5)
T2w MRI
(n = 5)
Condition (a): 
Auto seg
(operator N/A)
Condition (b): 
Semiauto seg
(operator i)
Condition (c): 
Manual seg
(operator j ≠ i)
Editing
(operator i)
Editing
(operator i)
Editing
(operator i)
Editing metrics
(auto seg)
Editing metrics
(semiauto seg)
Editing metrics
(manual seg)
Comparison of spatial and temporal metrics
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entire experiment; operator #j only provided manual reference segmentations and did not 
take part in this editing study in any other way. Editing was performed in slice-by slice 
mode using the ITK-SNAP interface on axially-oriented slices. Changes were applied 
only on the axial slices but sagittal and coronal views were also provided to the operator 
during editing, so the operator could check for spatial coherence of the segmentations in 
these views. The operators used the adjustable-size paint brush tool in ITK-SNAP to 
add/remove area to/from the segmentation labels. They were able to adjust window and 
level and zoom in and out during editing. Spatial and temporal metrics were collected for 
each of the three conditions to compare the editing that was performed within each 
operator and between operators. To enable direct comparison of the editing of the 
automatic and semi-automatic segmentations, we used the same subset of 5 MRI scans 
for each operator for these two conditions. To mitigate possible effects of the order of 
MRI scan presentation on the experiment, the 15 segmentations were presented in a 
different randomized order for each operator, with a constraint that between any two 
presentations of the same MRI scan to the operator (i.e. once for automatic segmentation, 
and again with the same scan for semi-automatic segmentation), there were at least six 
MRI scans from other patients presented. 
4.2.3 Spatial editing magnitude and inter-operator variability 
We compared the pre-editing segmentations to the post-editing segmentations in 
each of the three conditions shown in Figure 4.1, answering research question (1). We 
used five different metrics, including MAD, DSC, recall, precision and volume difference 
(ΔV), to perform comparisons in terms of surface disagreement, regional misalignment 
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and volume difference. Where applicable, the post-editing segmentation was defined as 
the reference segmentation. These metrics are defined in detail below. 
4.2.3.1 Mean absolute distance 
The MAD metric measures the disagreement between two 3D surfaces as the 
average of a set of Euclidean distances between corresponding surface points of two 
shapes. For each point on one surface, the closest point on the other surface is defined as 
the corresponding point. Equation (4.1) shows the MAD of X and Y as two surface point 
sets, where D(p,q) is the Euclidean distance between points p and q. A MAD of zero 
indicates ideal agreement between two shapes. 
 
𝑀𝐴𝐷(𝑋, 𝑌) =
1
𝑁
∑ min
𝑞∈𝑌
𝐷(𝑝, 𝑞)
𝑝∈𝑋
 (4.1) 
The MAD calculation needs to consider one of the shapes as the reference (e.g. 
point set Y is the reference in equation (4.1). Therefore, when two segmentations are to be 
compared and there is no reference segmentation, we use the bilateral MAD which is the 
average of the two MAD values obtained using each segmentation as the reference. 
4.2.3.2 Dice similarity coefficient 
The DSC is a region-based metric that measures the proportion of the volume of 
the overlap region between two shapes and the average of their volumes in 3D (equation 
(4.2)). The DSC is a unitless metric and will be 100% in the case of ideal segmentation 
and 0 when there is no overlap. 
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4.2.3.3 Recall and precision rates 
Recall (or sensitivity) and precision are also unitless error metrics that measure 
the regional misalignment in terms of the overlap region with 100% and 0 as the ideal 
and worst-case measurement values, respectively. To calculate recall and precision, we 
need to consider one shape as the reference. Recall measures the proportion of the 
reference that is within the segmentation (equation (4.3)) and precision measures the 
proportion of the segmentation that is within the reference (equation (4.4)). 
 
𝐷𝑆𝐶(𝑋, 𝑌) =
2(𝑋 ∩ 𝑌)
𝑋 + 𝑌
=
2𝑇𝑃
𝐹𝑃 + 2𝑇𝑃 + 𝐹𝑁
× 100 , (4.2) 
 
𝑅𝑒𝑐𝑎𝑙𝑙(𝑋, 𝑌) =
𝑇𝑃
𝑇𝑃 + 𝐹𝑁
× 100 , 
(4.3) 
 
𝑃𝑟𝑒𝑐𝑖𝑠𝑖𝑜𝑛(𝑋, 𝑌) =
𝑇𝑃
𝑇𝑃 + 𝐹𝑃
× 100 , 
(4.4) 
where TP is the true positive or correctly identified region, FP is the false positive or 
incorrectly identified region, and FN is the false negative or incorrectly ignored region 
(see Figure 3.2). 
4.2.3.4 Volume difference 
To calculate ΔV we subtract the reference shape volume from the segmentation 
shape volume. Therefore ΔV is a signed error metric; i.e. negative values of ΔV show 
that the segmentation is smaller than the reference and positive values of ΔV show that 
the segmentation is larger than the reference. 
To quantify inter-operator variability in segmentation and editing (answering 
research question (2)), we calculated simultaneous truth and performance level 
estimation (STAPLE) [24] consensus segmentations from the five operator segmentations 
before and after editing under all three conditions, with two exceptions. In the case of the 
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pre-editing automatic segmentations, no operators were involved, so no STAPLE 
segmentation was calculated. In the case of the pre-editing manual segmentations, only 
the segmentations of a single operator #j were edited in this study. To obtain a measure of 
inter-operator variability in pre-editing manual segmentations, we computed a STAPLE 
segmentation from manual segmentations performed by three of our operators on the 
same five images that were used for manual segmentation editing in our study. There 
were thus five sets, each containing five segmentations performed by different operators, 
with accompanying STAPLE consensus segmentation: (1) pre-editing semi-automatic, 
(2) post-editing semi-automatic, (3) post-editing automatic, (4) pre-editing manual, and 
(5) post-editing manual. Within each of these five sets, our five segmentation error 
metrics were computed to compare each operator’s segmentation to the corresponding 
STAPLE segmentation, with the means of the metric values indicating the amount of 
inter-operator variability. We used one-tailed pairwise heteroscedastic t-tests to test for 
statistical significance of differences in these inter-operator variability measurements 
between paired elements of the five sets. This allows us, for instance, to measure whether 
there is a statistically significant reduction of inter-operator variability in edited semi-
automatic segmentations, versus edited automatic segmentations. 
4.2.4 Required editing time and correlation with spatial error metrics 
For each label, we recorded the interaction time that was required to have a 
clinically acceptable segmentation using manual, semi-automatic and automatic 
segmentation methods, answering research question (3). We recorded the time from the 
moment when the operator began reviewing and editing the segmentation until the 
moment the operator verbally confirmed that the segmentation was ready to be used in 
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clinic. The editing time included browsing through the slices in the 3D volume, 
reviewing the segmentation, adding to and removing from the segmentation, window and 
level adjustment, editing tool selection and adjustment, and zooming in and out. For each 
of the three conditions, we calculated the mean and standard deviation of the interaction 
time across the five presented MRI scans separately for each operator, and also in 
aggregate across all five operators. For the semi-automatic algorithm we measured the 
interaction time required for algorithm operation and included this interaction time as part 
of the time required for the condition involving semi-automatic segmentation. 
We measured the degree to which measured spatial error metric values can be 
used as surrogates for the amount of editing time needed to achieve a segmentation that is 
satisfactory to the operator, answering research question (4). To do this, we calculated all 
five of our error metrics for the whole gland, apex, mid-gland, and base, comparing the 
pre-editing segmentation to the post-editing segmentation for the automatic and semi-
automatic segmentations (conditions 1 and 2 in Figure 4.1), using the post-editing 
segmentation as the reference where applicable. We measured the monotonicity of the 
relationship between each metric value and editing time using Spearman’s rank-order 
correlation (ρ). We tested the statistical significance of the correlation coefficients using 
the null hypothesis that there was no association between the error metric values and 
editing time values. For all tests, the sample size was 50 (10 images each contoured by 5 
operators). 
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4.3 Results 
4.3.1 Spatial editing magnitude and inter-operator variability 
Figure 4.4 shows the spatial magnitude of editing required for automatic, semi-
automatic, and manual segmentations for operators to achieve final edited segmentations 
suitable for clinical use. As might be expected, the general trend is that the automatic 
segmentations required the most editing, followed by the semi-automatic and manual 
segmentations. However, this trend was not reflected in all of the error metrics. For 
instance, looking at the DSC and recall metrics, we detected no significant difference in 
the amount of editing applied to the automatic vs. semi-automatic segmentations. 
Operator editing of manual segmentation consistently decreased segmentation volume 
without substantially affecting precision. This suggests that the manual pre-editing 
segmentations were deemed by the operators to be oversegmentations, and editing drew 
the boundaries inward by an amount reflected by the MAD metric values in Figure 4.4 
(MAD < 1 mm in general). Figure 4.3 shows the inter-operator variability in 
segmentation before and after editing, reported using the mean of each segmentation 
error metric across all operators for each image, with respect to a STAPLE reference 
standard. This analysis revealed significant differences in inter-operator variability for 
most of the conditions, for all metrics expect for the volume difference. Note the 
substantial inter-operator variability in manual segmentation (reflected by large mean 
metric values and large variability indicated by the whiskers) for many metrics, relative 
to the inter-operator variability in semi-automatic and automatic segmentations, even 
when manual editing is applied (e.g. compare the “manual-pre” measurements to the 
other measurements for the MAD metric in Figure 4.3). Overall, post-editing variability 
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is lower than pre-editing variability, with post-editing automatic and semi-automatic 
segmentations having similar variability. The MAD, DSC, and precision metrics revealed 
that editing reduced the amount of inter-operator variability for the semi-automatic 
segmentation condition (compare SA (pre) to SA (post) in Figure 4.3 for these three 
metrics). Interestingly, a similar pattern was observed for the manual segmentations. No 
significant differences were found between pre-editing manual segmentations and 
computer-assisted segmentations for any of the conditions or metrics. Post-editing 
automatic segmentation consistently demonstrated lower variability than pre-editing 
semi-automatic segmentation. No significant differences were found between post-
editing automatic segmentation and post-editing semi-automatic segmentation. 
Table 4.2: User manual interaction time for ready to use prostate segmentation in T2w 
MRI. 
Segmentation labels No. of images No. of Operators User interaction time  
Manual 5 5 213 ± 90 sec (3:33 ± 1:30 min) 
Semi-automatic 5 5 328 ± 126 sec (5:28 ± 2:06 min) 
Semi-automatic (user interaction time included) 5 5 351 ± 128 sec (5:51 ± 2:08 min) 
Automatic 5 5 393 ± 146 sec (6:33 ± 2:26 min) 
134 
 
  
Figure 4.2: User manual interaction time on manual, semi-automatic (S.A.) and 
automatic segmentations.The statistically significant differences indicated with * on the 
averages of the groups across all the five images (p < 0.05). 
4.3.2 Required editing time and correlation with spatial error metrics 
Table 4.2 shows the mean ± standard deviation of the recorded time required for 
each of the three conditions. For the semi-automatic condition, the time required only for 
editing, as well as the time required for editing plus the time required to interact with the 
semi-automated algorithm, are reported separately. Figure 4.2 shows the breakdown of 
these editing times for each image. Significant differences were found between editing 
times for all conditions, except when comparing automatic segmentation to semi-
automatic segmentation. To provide context for these editing times, according to the 
literature, the time required for manual prostate delineation on MRI can range from 
approximately 5 minutes [25] to approximately 20 minutes per patient [26], or about 1.6 
minutes for each 2D slice [27]. Our experience is concordant with this reported time 
range; timing of manual segmentation on the five images used in conditions (a) and (b) 
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for one expert operator yielded a mean ± standard deviation segmentation time of 564 ± 
162 sec (9:20 ± 2:42 min). Based on Table 4.2, we observe that operators spent 
approximately 2–3 additional minutes editing computer-assisted segmentations, 
compared to the amount of time spent editing manual segmentations performed by a 
different expert operator. 
4.3.3 Correlation of editing time with the metric values 
Table 4.3 shows the correlations between editing time and spatial editing 
magnitudes as measured using our segmentation error metrics. There were few significant 
correlations and none had magnitude > 0.5. Significant correlations were predominantly 
in the base of the gland. In the base, recall was positively correlated with editing time, 
and precision and volume difference were negatively correlated with editing time. This 
pattern was observed in the whole gland as well but only weakly in the mid-gland and not 
in the apex. 
Table 4.3: Correlation between editing time and spatial editing magnitude measured 
using five metrics. Each value is the Spearman’s correlation coefficient between the 
value of each error metric and editing time. The bold numbers indicate statistically 
significant correlations (p < 0.05) 
Anatomic region MAD DSC Recall Precision ΔV 
Whole gland 0.204 0.18 0.361 -0.341 0.417 
Apex 0.206 -0.081 -0.194 -0.138 0.092 
Mid-gland 0.263 -0.149 0.149 -0.282 0.312 
Base -0.14 0.367 0.428 -0.305 0.406 
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Figure 4.3: Inter-operator variability.  Each bar shows the average metric value for one 
image across five operators. The error bars indicate one standard deviation. The 
horizontal lines indicated statistically significant differences on the averages of the 
groups across all the five operators and five images (p < 0.05). SA: semi-automatic. 
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Figure 4.4: Editing magnitude, showing the differences between the segmentations pre- 
and post-editing for each of the three conditions.Each bar shows the average metric value 
for one image across five operators. The error bars indicate one standard deviation. The 
horizontal lines indicated statistically significant differences on the averages of the 
groups across all the five operators and five images (p < 0.05). 
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4.4 Discussion 
4.4.1 Spatial editing magnitude and inter-operator variability 
As shown in Figure 4.4, there was a nonzero difference between pre-editing and 
post-editing expert manual segmentations for all metrics. The amount of editing 
performed on the manual segmentations provides valuable perspective on the amount of 
editing performed on the automatic and semi-automatic segmentations. One might expect 
that improvements to computer-assisted segmentation algorithms would require amounts 
of editing asymptotically approaching the amounts of editing that operators deem 
necessary for expert manual segmentations provided by other experts (i.e. expert 
operators would elect to edit outputs from even an ideal computer-assisted segmentation 
algorithm). For studies of computer-assisted segmentation algorithms using single-
operator manual reference standard segmentations for validation, this observation is 
especially important; this suggests that algorithms yielding segmentation error metric 
values within the range observed in expert editing of manual expert segmentations could 
be considered to have essentially the same performance. For instance, Figure 4.4 would 
suggest that two algorithms reporting DSC values of 94% and 96% would be considered 
to perform equally, as these values are well within the range of manual editing of manual 
segmentations. This observation could have ramifications for the ranking schemes used 
for segmentation grand challenges (such as PROMISE12 [28]), suggesting a practical 
equivalence of some top-ranked algorithms and a potential means for deciding when top-
ranked algorithms are ready to be moved to the next stage of translation to clinical use. 
Although some metrics revealed a significant difference in the amount of editing required 
for automatic vs semi-automatic segmentations, this significance (and the magnitude of 
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the difference) varied across metrics. This observation emphasizes the need for multiple, 
complementary spatial metrics to comprehensively assess the performance of a 
segmentation algorithm. 
Our analysis in Figure 4.3 indicates that in general, allowing operators to edit 
provided segmentations reduces inter-operator variability in segmentation, compared to 
the inter-operator variability resulting from manual segmentations performed from 
scratch. The trend held even when comparing manual segmentations performed from 
scratch to manual segmentations that have been edited to satisfaction by another operator. 
This result underscores the value of providing operators with a starting segmentation for 
editing as this could improve the reproducibility of prostate segmentation, which is 
important for multi-operator clinical trials and consistency of patient care in clinical 
practice. Whereas the lowest inter-operator variability resulted from giving operators a 
starting segmentation performed manually by another expert, in clinical practice this is 
clearly impractical. From this perspective, the automatic segmentation could be seen as a 
practical alternative approach to obtain the starting segmentation. Although the difference 
in inter-operator variability between post-editing manual segmentations and post-editing 
automatic segmentations was statistically significant, inspection of Figure 4.3 reveals that 
this difference is very small from a practical perspective. This leads to the hypothesis that 
providing operators with an automatic segmentation with accuracy metric values similar 
to ours (Table 4.1) as a starting point will yield superior inter-operator reproducibility 
even after editing, compared to manual segmentations performed from scratch. This 
hypothesis needs to be tested in a larger study covering a broader range of segmentation 
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algorithms, a larger data set, and a larger pool of operators having different experience 
levels. 
4.4.2 Required editing time and correlation with spatial error metrics 
Our results suggest that the use of automatic or semi-automatic segmentation 
algorithms to provide a starting segmentation for editing should reduce the total amount 
of time required to achieve a clinically acceptable segmentation, relative to typical 
reported times required for manual segmentations performed from scratch. Our results 
also suggest that the difference in total time required to use our automatic vs semi-
automatic segmentation algorithms for this purpose is small, when the time required to 
interact with the semi-automatic segmentation algorithm is taken into account. Thus, the 
choice in this regard may come down to operator preference; the semi-automatic 
segmentation algorithm allows the operator to specify the apex-to-base extent of the 
prostate, reducing the need for editing involving adding or removing entire slices in these 
regions. This comes at the cost of needing to wait for < 60 seconds for the segmentation 
to be computed online, whereas the automatic segmentations can be computed offline 
immediately after MRI scanning and thus would appear instantaneously to the operator at 
time of editing. Our results also showed that operators spent more time editing the 
computer-assisted segmentations, compared to the time spent editing manual 
segmentations by another expert operator. We posit that this difference in editing time is 
an important metric for determining the suitability of a computer-assisted segmentation 
algorithm for translation to clinical use in scenarios where for safety or other reasons, 
expert operator verification for necessary editing will be performed on every 
segmentation. From this perspective, there is room for improvement in our semi-
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automatic and automatic algorithms of approximately 2–3 minutes of editing time per 
prostate in order to achieve concordance with the amount of editing performed on manual 
segmentations. 
Table 4.3 indicates a consistent negative correlation of the precision metric value 
with editing time, with statistically significant correlations in all anatomic regions except 
for the apex. This implies that the greater the false positive area in a computer-assisted 
segmentation, the greater the time that will be required to edit the segmentation to a 
clinically acceptable level. This is corroborated by the consistent positive correlation with 
the volume difference metric (again, significant everywhere except the apex), implying 
that the greater the amount of oversegmentation performed by computer-assisted 
segmentation algorithm, the more editing time that will be required. Comparing the 
correlation coefficients for precision and volume difference within the apex, mid-gland, 
and base, the strongest correlations were found in the base region. This implies that the 
above relationships are especially applicable for false positive regions and 
oversegmentation of the base. However, based on these observations one could make 
only a weak recommendation that the amount of necessary editing time could be 
estimated based on the precision and volume difference spatial error metric values; 
although the correlation coefficients are statistically significant in many cases, they do 
not have high magnitude. 
The lack of strong correlations in Table 4.3 implies weak relationships between 
editing time and spatial editing magnitudes as measured by our segmentation error 
metrics. The observations in the previous paragraph notwithstanding, this implies that in 
general, one cannot use spatial metrics such as the MAD, DSC, precision, recall, and 
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volume difference to estimate the amount of time that an operator will require to produce 
a clinically acceptable segmentations using the output of a segmentation algorithm as a 
starting point. This is an important observation since in most clinical workflows, time is a 
scarce and valuable resource; if it takes (nearly as) long to edit a segmentation from an 
algorithm as it does to perform a manual segmentation from scratch, the clinician may be 
inclined toward the simpler approach of performing manual segmentation. We surmise 
that this issue is a major contributor to the present state of affairs, where the academic 
literature has produced many hundreds of computer-assisted segmentation algorithms and 
yet very few of them have moved forward to clinical use. This leads to the conjecture that 
the most important metrics to compute when evaluating the suitability of an algorithm for 
clinical translation are operator variability, measured using spatial metrics such as MAD, 
DSC, etc., and editing time, measured directly using a sample of multiple operators. 
Viewed through this lens, the ideal segmentation algorithm would yield low operator 
variability and low editing time. This suggests that a potential reevaluation of the use 
spatial metrics for measuring segmentation accuracy may be in order, since in most 
practical clinical workflows, the final segmentation as edited and approved by the 
clinician will be used for its clinical purpose and could be considered 100% “accurate” 
for practical purposes. This observation supports engineers and computer scientists 
aiming for the concrete goal of producing a clinically useful segmentation in a minimum 
amount of time, in lieu of setting our aims according to the nebulous notion of accuracy, 
with all of its attendant issues (e.g. differing expert opinions on what constitutes a correct 
segmentation, issues regarding whether “gold standard” expert segmentations truly 
delineate the histologic boundary of the target of interest). 
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Comparing our algorithms to a hypothetical segmentation algorithm that 
demonstrated better performance based all five introduced error metrics in a multi-
operator and multi-reference study, and noting that no such algorithm has been reported 
in the literature due to a lack of comprehensive validation: 
(1) We expect that less editing of the segmentation results would be required, but 
not less than the amount of editing applied by an expert on to a manual segmentation 
provided by another expert. 
(2) Since there was not a big difference in terms of editing time measured for 
automatic and semi-automatic segmentation algorithms, and no strong correlation 
between segmentation error metric values and the required editing time, we cannot 
speculate as to whether this hypothetical algorithm would result in reduced editing time. 
(4) We acknowledge that our observed lack of correlation between spatial error 
metric values and editing time only applies to the range of spatial error metric values that 
we observed for our algorithms.  Such a correlation is possible for different error metric 
value ranges; e.g. containing the better metric values given by this hypothetical 
algorithm. 
4.4.3 Limitations 
This work must be considered in the context of its strengths and limitations. We 
acknowledge that given our image sample size and number of operators participating in 
the study, in some aspects, this is a descriptive, hypothesis-generating study that points 
the way to potentially fruitful studies on larger sample sizes with sufficient statistical 
power to draw firmer conclusions. We also acknowledge that although the editing 
interface we used, involving a mouse-driven variable-sized paintbrush tool, is concordant 
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it its mode of operation with the interfaces used in many clinical workflows, it does 
constitute only a single mode of performing segmentation editing. Thus, our study 
generates no knowledge about the impact of the choice of editing tool on editing times, 
and this would be a subject of valuable further study. Finally, in this user study we tested 
only two computer-assisted segmentation algorithms; a more comprehensive future study 
involving a broader cross-section of current algorithms is warranted. 
4.4.4 Conclusions 
In this chapter, we conducted a user study measuring the amount of spatial editing 
performed by expert users on segmentations generated manually, semi-automatically, and 
automatically. We measured the inter-operator variability in segmentation before and 
after editing, and measured the relationship between editing magnitude and time spent 
editing. With reference to the enumerated research questions in the introduction section 
of this chapter, we have reached four main conclusions, with the acknowledgment that 
our sample size implies that these conclusions should be considered as hypotheses to test 
in future, larger studies. (1) As would be expected, the operators performed the most 
spatial segmentation editing on the automatic segmentations, followed by the semi-
automatic segmentations, and the least amount of editing on the manual segmentations. 
The measured editing magnitudes varied according to the error metric used, reinforcing 
the value of using multiple, complementary error metrics in segmentation studies, rather 
than focusing on one or two typically used metrics (e.g. the MAD and DSC). (2) 
Providing operators with a starting segmentation for editing, either performed manually 
by another operator or (semi-)automatically via an algorithm, yielded lower inter-
operator variability in the final segmentation, compared to inter-operator variability in 
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manual segmentations performed from scratch (as is frequently performed in clinical 
workflows currently). Inter-operator variability resulting from using our automatic 
algorithm to generate starting segmentations was not substantially higher than that 
resulting from using expert manual segmentations as starting segmentations, suggesting a 
role for our automated segmentation algorithm in this context. (3) The use of our 
automatic or semi-automatic segmentation algorithms to generate starting segmentations 
for editing is expected to decrease the total required segmentation time, compared to the 
time required to perform manual segmentations from scratch, and the choice of automatic 
vs. semi-automatic segmentation for this purpose comes down to operator preference. (4) 
The necessary time requirement for segmentation editing cannot be reliably predicted 
from spatial segmentation error metrics in all anatomic regions of the prostate. Thus, for 
the many clinical workflows where manual segmentation review and editing will be 
performed for safety and other reasons, and minimization of editing time is a primary 
goal, the fact that one algorithm outperforms another in terms of spatial metrics such as 
the MAD and DSC does not imply that the algorithm is more suitable for clinical 
translation. In such contexts, where the medical expert’s final edited segmentation is 
taken as correct for practical purposes, the ideal segmentation algorithm supports the 
expert’s obtaining of a clinically acceptable segmentation in a minimum amount of time 
while minimizing inter-operator segmentation variability. This increases the volume of 
patients that can be treated and simultaneously supports consistent quality of the 
intervention patients receive. 
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Chapter 5. 
  
Conclusions and directions for future work 
5.1 Conclusions 
The work in this thesis has resulted in the following advances in technology and 
knowledge, enumerated according to the objectives given in Section 1.9: 
1. Chapter 2 described a novel system for semi-automatic prostate segmentation 
on T2w ER MRI. An important aspect of this system is that the main computational step 
of the segmentation is in computing loci of candidate boundary points, and our algorithm 
is such that the estimation of each locus is completely independent of all other loci, with 
regularization as a post-processing step. Therefore, the algorithm has high potential for 
further speedup via a parallel computing implementation. The accuracy and inter-
observer variability of this system was measured using a set of complementary error 
metrics on multiple anatomic regions of interest within the prostate. We used a validation 
methodology in which three different types of error (surface disagreement, region 
misalignment and volume difference) in segmentation results were quantified using five 
error metrics. The error measurements were applied to the prostate gland as a whole, and 
to the apex, midgland and base regions separately. The system improved the 
reproducibility of the prostate segmentation, compared to manual segmentation, 
supporting the central hypothesis of this thesis. The system was shown to require 
minimal user interaction (30 seconds). Our results showed that the choice of manual 
reference segmentation had the biggest impact on segmentation variability, reinforcing 
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the need for multi-operator reference standard segmentations for algorithm validation. 
This study also showed that not only is prostate apex and base challenging (both semi-
automatically and manually), but in fact there is high inter-observer variability in even 
defining the apex-most and base-most extents of the prostate. This sheds light on the 
most critical areas of focus for future development of prostate segmentation algorithms 
on MRI. 
2. Chapter 3 described a novel system for automatic prostate segmentation on 
T2w ER MRI, with accuracy and inter-observer variability measured as in Chapter 2. 
This method takes advantage of the availability of prostate size measurements that are 
obtained during clinical standard TRUS imaging prior to MRI to facilitation an automatic 
coarse localisation of the prostate prior to segmentation refinement using the same 
algorithm as presented in Chapter 2. This method replaced the 30 seconds of manual 
operator interaction time required to use the semi-automatic method in Chapter 3 with 3 
seconds of computation time, at the expense of a statistically significant but small 
decrease in accuracy. The use of the automated algorithm substantially mitigated the 
inter-observer variability observed in Chapter 2 of the segmentation of the base region of 
the prostate by eliminating the need for an operator to decide on the apex-most and base-
most extents of the gland, supporting the central hypothesis of this thesis. The automatic 
algorithm provided improved accuracy, compared to the semi-automatic algorithm, in 
measuring overall prostate volume. 
3. Chapter 4 described an expert user study measuring the impact of using semi-
automatic and automatic segmentations on physicians’ ability to obtain a clinically 
acceptable segmentation via editing a provided starting segmentation, compared to 
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achieving the same end via fully manual segmentation. Although the amount of editing 
required was directly proportional to the amount of automation used to produce the 
starting segmentation (i.e. via fully automated, vs semi-automated, vs manual 
segmentation by another operator), the use of an automatically generated starter 
segmentation yielded lower inter-operator segmentation variability in the final 
segmentation, compared to from-scratch manual segmentation, supporting the central 
hypothesis of this thesis. Using such a starter segmentation was also found to reduce the 
total time required to achieve a clinically acceptable segmentation, also supporting the 
central hypothesis of this thesis. Finally, we found that spatial error metrics such as the 
MAD and DSC are not strongly correlated with the amount of editing time required to 
render a segmentation clinically acceptable. This observation challenges the comparison 
between two algorithms’ performance based on the values of the spatial metrics. Since 
for clinical purposes, a segmentation judged by a physician to be clinically acceptable can 
be taken to be accurate (because the physician will use this segmentation for the 
intervention at hand), the practical purposes of computer-assisted segmentation are (1) to 
assist the physician in obtaining a segmentation that is clinically acceptable to him/her in 
less time than would be required for manual segmentation, and (2) to increase 
consistency of patient care for procedures depending on prostate segmentation on MRI. 
Thus, to evaluate an algorithm’s suitability for clinical translation, algorithm developers 
need to directly measure the required editing time for multiple operators to achieve 
clinically acceptable segmentations; spatial error metrics cannot be used as a surrogate 
for editing time. Rather, the value of  spatial error metrics is in measuring inter-operator 
segmentation variability; decreasing this variability is a step toward increasing 
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consistency of patient care and increasing consistency of execution of multi-operator and 
multi-centre clinical trials involving prostate segmentation on MRI. 
5.2 Applications and future directions 
The segmentation techniques and evaluation methods developed in this thesis 
support research applications in which prostate segmentation in T2w ER MRI is either 
being studied or being employed, or clinical applications that require prostate 
segmentation on T2w ER MRI. In the following section, several applications that could 
potentially benefit the segmentation algorithm will be discussed. Some remaining gaps in 
knowledge that could be covered as part of future work will also be discussed. 
5.2.1 Applications in ongoing clinical research studies 
In an ongoing clinical research studies in our group [1], for a mechanically-
assisted targeted prostate biopsy system, surface-based MRI-TRUS registration was 
required. The TRUS images were segmented using a semi-automatic algorithm. For the 
MR images, manual segmentation of the prostate was used. Our segmentation algorithms 
could be used to facilitate the surface-based image registration and MRI-TRUS fusion, to 
decrease processing time and mitigate inter-observer variabiility. The impact of MRI 
segmentation error and variability on the MRI-TRUS registration error could be studied 
before and after applying manual editing to the segmentation labels, with the ultimate 
endpoint being the impact on positive yield at biopsy as measured in a prospective study.  
In another clinical research study [2, 3], manual segmentation of the prostate on 
T2w MRI has been employed in an MRI-compatible mechatronic system that was 
developed for MRI-guided needle insertion to the prostate. In this system, a preoperative 
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and an intraoperative ER prostate MR image are manually segmented and registered 
together for mapping defined targets from the preoperative image to the intraoperative 
image. Our segmentation algorithms could be applied to both pre- and intra-operative 
images. Our automated algorithm could be particularly helpful to speeding up the 
intraoperative MR image segmentation to reduce the total amount of in-bore procedure 
time required. 
There are also other research studies or clinical applications in which ER prostate 
MRI segmentation is required [4, 5]. In these studies manual prostate segmentation on 
pre-operative T2w MRI was used for surface-based image registration between pre-
operative MRI and either intra-operative MRI or pre-operative ultrasound to localize PCa 
tumours in image-guided biopsy or focal therapy. Therefore, the impact of using our 
algorithm could be investigated in terms of processing time and/or procedure accuracy 
and reproducibility, compared to using manual segmentation. 
5.2.2 Suggestions for future work 
We have studied the accuracy and reproducibility of a segmentation algorithm as 
well as the segmentation time that is required to have clinically acceptable contours. To 
the best of our knowledge, the impact of segmentation error on the final results of a 
clinical procedure has not been extensively studied; e.g. the impact of MRI segmentation 
error on PCa targeting in an MRI-targeted TRUS-guided prostate biopsy, or on the results 
of radiation therapy dosimetry. Hence, it is also important to study the impact of the 
segmentation error and variability, before and after manual editing, on the performance of 
some of the clinical applications in which ER prostate MRI segmentation is used. 
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The presented segmentation approaches, although highly amenable to parallel 
implementation, were implemented sequentially. Hence, an important future step for this 
work would be implementation of the algorithm for parallel computing on a graphics 
processing unit (GPU), and we would expect at least an order of magnitude lower 
computation times from such an implementation. Using an unoptimized implementation 
of the algorithm on a Matlab research platform and running on a single central processing 
unit core, the segmentation takes less than 90 seconds, on average. We would expect a 
GPU implementation to therefore run in well under 10 seconds. 
Our observation of no meaningful correlation between the values of the five error 
metrics used in this work and the required editing time to achieve a clinically acceptable 
segmentation leads to the recommendation that editing time must be measured directly 
for multiple observers in order to assess an algorithm’s suitability for clinical translation. 
This renders algorithm evaluation much more expensive in terms of time and effort, and 
requires the engagement of clinical colleagues which is challenging in many computer 
science and engineering contexts which may be located distant to clinical centres. There 
is therefore potential value in future work designing and validating novel spatial error 
metrics that are more accurately predictive of required editing time. The data set 
generated as part of our study in Chapter 4 could provide initial validation of novel 
metrics for this purpose. 
Since PCa tumours are most likely to be found within the peripheral zone of the 
prostate gland, in some the clinical applications the segmentation of the prostate gland 
into its zones could be helpful. Therefore, zonal segmentation of the prostate gland could 
be taken into account as another step forward. According to the appearance of the 
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peripheral zone in T2w MRI (i.e. usually a brighter region compared to the surrounding 
tissues) the same local appearance-based segmentation method we used for whole 
prostate gland segmentation might be also applicable for zonal segmentation of the gland. 
This segmentation method could also be utilized in segmentation of any other 
organs or objects that have convex shapes and inter-patient local appearance consistency 
withing different parts of the object boundary, despite of inter-patient appearance 
differences inside or outside of the object. 
Finally, The conclusions of this work are valid only in the context of our own 
segmentation techniques, and the results might differ if the operator editing study were 
conducted with different algorithms. Moreover, due to the small size of the data sets  and 
the number of operators involved, this should be considered to primarily be a set of 
hypothesis-generating studies that point the way to potentially fruitful studies on larger 
sample sizes with sufficient statistical power to draw firmer conclusions. We also did not 
study the effect of MR pulse sequence parameters on the results. 
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